{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:59:49Z","timestamp":1790200789305,"version":"4.1.0"},"reference-count":423,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":427,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1002\/hep.27191","type":"journal-article","created":{"date-parts":[[2014,4,29]],"date-time":"2014-04-29T08:21:41Z","timestamp":1398759701000},"page":"362-398","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":221,"title":["Evaluation of the Pediatric Patient for Liver Transplantation: 2014 Practice Guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition"],"prefix":"10.1097","volume":"60","author":[{"given":"Robert H.","family":"Squires","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udeme","family":"Ekong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winita","family":"Hardikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukru","family":"Emre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George V.","family":"Mazariegos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-40-20250207","doi-asserted-by":"crossref","first-page":"14071432","DOI":"10.1002\/hep.20704","article-title":"AASLD practice guidelines: evaluation of the patient for liver transplantation.","volume":"41","author":"Murray","year":"2005","journal-title":"Hepatology"},{"key":"R2-40-20250207","first-page":"314317","article-title":"Informed consent, parental permission, and assent in pediatric practice.","volume":"95","year":"1995","journal-title":"Pediatrics"},{"key":"R3-40-20250207","first-page":"128134","article-title":"Delayed encephalopathy in fulminant hepatic failure in the pediatric population and the role of liver transplantation.","volume":"24","author":"RiveraPenera","year":"1997","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R4-40-20250207","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1111\/j.1399-3046.2010.01411.x","article-title":"Cognitive and adaptive functioning after liver transplantation for maple syrup urine disease: a case series.","volume":"15","author":"Shellmer","year":"2011","journal-title":"Pediatr Transpl"},{"key":"R5-40-20250207","doi-asserted-by":"crossref","first-page":"793800","DOI":"10.1007\/s12098-012-0704-1","article-title":"Primary malignant liver tumors in children.","volume":"79","author":"Agarwala","year":"2012","journal-title":"Indian J Pediatr"},{"key":"R6-40-20250207","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1111\/j.1399-3046.2005.00395.x","article-title":"Hepatocellular carcinoma in children and effect of livingdonor liver transplantation on outcome.","volume":"10","author":"Arikan","year":"2006","journal-title":"Pediatr Transpl"},{"key":"R7-40-20250207","doi-asserted-by":"crossref","first-page":"467474","DOI":"10.1016\/j.jpeds.2005.12.054","article-title":"A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000.","volume":"148","author":"Shneider","year":"2006","journal-title":"J Pediatr"},{"key":"R8-40-20250207","doi-asserted-by":"crossref","first-page":"339342","DOI":"10.1097\/00007890-199508270-00007","article-title":"Liver transplantation in children with Alagille syndromea study of twelve cases.","volume":"60","author":"Cardona","year":"1995","journal-title":"Transplantation"},{"key":"R10-40-20250207","doi-asserted-by":"crossref","first-page":"409421","DOI":"10.1007\/s11938-001-0006-6","article-title":"Endstage liver disease in children.","volume":"4","author":"Squires","year":"2001","journal-title":"Curr Treat Opt Gastroenterol"},{"key":"R11-40-20250207","doi-asserted-by":"crossref","first-page":"503513","DOI":"10.1097\/MPG.0b013e318213f9f6","article-title":"Pathophysiology, diagnosis, and management of pediatric ascites.","volume":"52","author":"Giefer","year":"2011","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R12-40-20250207","doi-asserted-by":"crossref","first-page":"639645","DOI":"10.1016\/S0168-8278(99)80194-9","article-title":"Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial.","volume":"30","author":"Gentilini","year":"1999","journal-title":"J Hepatol"},{"key":"R13-40-20250207","doi-asserted-by":"crossref","first-page":"11871191","DOI":"10.1016\/S1542-3565(05)00861-X","article-title":"Management of refractory ascites.","volume":"3","author":"Cardenas","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R14-40-20250207","first-page":"245249","article-title":"Largevolume paracentesis in the management of ascites in children.","volume":"33","author":"Kramer","year":"2001","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R15-40-20250207","doi-asserted-by":"crossref","first-page":"594600","DOI":"10.1097\/MPG.0b013e3182490c05","article-title":"Feasibility and efficacy of transjugular intrahepatic portosystemic shunt (TIPS) in children.","volume":"54","author":"Di Giorgio","year":"2012","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R16-40-20250207","doi-asserted-by":"crossref","first-page":"751755","DOI":"10.1097\/MPG.0b013e318213be81","article-title":"Variation in care for children with esophageal varices: a study of physicians, patients, and families approaches and attitudes.","volume":"52","author":"Gana","year":"2011","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R17-40-20250207","first-page":"211218","article-title":"Medical management of esophageal varices and portal hypertension in children.","volume":"21","author":"DAntiga","year":"2012","journal-title":"Semin Pediatr Surg"},{"key":"R18-40-20250207","doi-asserted-by":"crossref","first-page":"426437","DOI":"10.1111\/j.1399-3046.2012.01652.x","article-title":"Portal hypertension in children: expert pediatric opinion on the report of the Baveno v Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension.","volume":"16","author":"Shneider","year":"2012","journal-title":"Pediatr Transpl"},{"key":"R19-40-20250207","doi-asserted-by":"crossref","first-page":"18131824","DOI":"10.1002\/lt.20910","article-title":"Recurrence of autoimmune liver disease after liver transplantation: a systematic review.","volume":"12","author":"Gautam","year":"2006","journal-title":"Liver Transpl"},{"key":"R20-40-20250207","doi-asserted-by":"crossref","first-page":"856863","DOI":"10.1002\/lt.22074","article-title":"Recurrent low gammaglutamyl transpeptidase cholestasis following liver transplantation for bile salt export pump (BSEP) disease (posttransplant recurrent BSEP disease).","volume":"16","author":"Siebold","year":"2010","journal-title":"Liver Transpl"},{"key":"R21-40-20250207","doi-asserted-by":"crossref","first-page":"239245","DOI":"10.1016\/j.cgh.2008.10.019","article-title":"A retrospective singlecenter review of primary sclerosing cholangitis in children.","volume":"7","author":"Miloh","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R22-40-20250207","doi-asserted-by":"crossref","first-page":"269274","DOI":"10.1002\/ibd.21692","article-title":"Risk of colonic neoplasia after liver transplantation for primary sclerosing cholangitis.","volume":"18","author":"Hanouneh","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"R23-40-20250207","first-page":"358363","article-title":"Body composition and components of energy expenditure in children with endstage liver disease.","volume":"36","author":"Greer","year":"2003","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R24-40-20250207","doi-asserted-by":"crossref","first-page":"11611183","DOI":"10.1016\/j.pcl.2009.06.005","article-title":"Optimizing nutritional management in children with chronic liver disease.","volume":"56","author":"Nightingale","year":"2009","journal-title":"Pediatr Clin North Am"},{"key":"R25-40-20250207","doi-asserted-by":"crossref","first-page":"401408","DOI":"10.1177\/0884533611405535","article-title":"Role of nutrition in pediatric chronic liver disease.","volume":"26","author":"Sultan","year":"2011","journal-title":"Nutr Clin Pract"},{"key":"R26-40-20250207","first-page":"13291331","article-title":"Increasing calories, decreasing morbidity and mortality: is improved nutrition the answer to better outcomes in patients with biliary atresia?","volume":"46","author":"CarterKent","year":"2007","journal-title":"Hepatology"},{"key":"R27-40-20250207","doi-asserted-by":"crossref","first-page":"16321638","DOI":"10.1002\/hep.21923","article-title":"Growth failure and outcomes in infants with biliary atresia: a report from the Biliary Atresia Research Consortium.","volume":"46","author":"DeRusso","year":"2007","journal-title":"Hepatology"},{"key":"R28-40-20250207","doi-asserted-by":"crossref","first-page":"203208","DOI":"10.1093\/ajcn\/52.2.203","article-title":"Anthropometric evaluation of children with chronic liver disease.","volume":"52","author":"Sokol","year":"1990","journal-title":"Am J Clin Nutr"},{"key":"R29-40-20250207","doi-asserted-by":"crossref","first-page":"340346","DOI":"10.1177\/0884533610374198","article-title":"Update in pediatrics: focus on fatsoluble vitamins.","volume":"25","author":"Sathe","year":"2010","journal-title":"Nutr Clin Pract"},{"key":"R30-40-20250207","doi-asserted-by":"crossref","first-page":"e607164","DOI":"10.1542\/peds.2011-1423","article-title":"Efficacy of fatsoluble vitamin supplementation in infants with biliary atresia.","volume":"130","author":"Shneider","year":"2012","journal-title":"Pediatrics"},{"key":"R31-40-20250207","doi-asserted-by":"crossref","first-page":"12171221","DOI":"10.1093\/ajcn\/53.5.1217","article-title":"Essential fatty acid deficiency associated with the use of a mediumchaintriglyceride infant formula in pediatric hepatobiliary disease.","volume":"53","author":"Pettei","year":"1991","journal-title":"Am J Clin Nutr"},{"key":"R32-40-20250207","doi-asserted-by":"crossref","first-page":"603607","DOI":"10.1136\/adc.67.5.603","article-title":"Intensive enteral feeding in advanced cirrhosis: reversal of malnutrition without precipitation of hepatic encephalopathy.","volume":"67","author":"Charlton","year":"1992","journal-title":"Arch Dis Child"},{"key":"R33-40-20250207","doi-asserted-by":"crossref","first-page":"217224","DOI":"10.1046\/j.1365-2265.2000.00934.x","article-title":"Nasogastric feeding enhances nutritional status in paediatric liver disease but does not alter circulating levels of IGFI and IGF binding proteins.","volume":"52","author":"Holt","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R34-40-20250207","doi-asserted-by":"crossref","first-page":"120128","DOI":"10.1002\/lt.22444","article-title":"Parenteral nutrition supplementation in biliary atresia patients listed for liver transplantation.","volume":"18","author":"Sullivan","year":"2012","journal-title":"Liver Transpl"},{"key":"R35-40-20250207","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1111\/j.1399-3046.2011.01598.x","article-title":"Overweight and obesity in pediatric liver transplant recipients: prevalence and predictors before and after transplant, United Network for Organ Sharing Data, 19872010.","volume":"16","author":"Perito","year":"2012","journal-title":"Pediatr Transpl"},{"key":"R36-40-20250207","doi-asserted-by":"crossref","first-page":"12961302","DOI":"10.1002\/lt.22162","article-title":"Impact of obesity on children undergoing liver transplantation.","volume":"16","author":"Dick","year":"2010","journal-title":"Liver Transpl"},{"key":"R37-40-20250207","doi-asserted-by":"crossref","first-page":"16621670","DOI":"10.1002\/lt.21952","article-title":"Posttransplant metabolic syndrome: an epidemic waiting to happen.","volume":"15","author":"Pagadala","year":"2009","journal-title":"Liver Transpl"},{"key":"R38-40-20250207","doi-asserted-by":"crossref","first-page":"10091028","DOI":"10.1002\/lt.23478","article-title":"Posttransplant metabolic syndrome in children and adolescents after liver transplantation: a systematic review.","volume":"18","author":"Rothbaum Perito","year":"2012","journal-title":"Liver Transpl"},{"key":"R39-40-20250207","doi-asserted-by":"crossref","first-page":"318328","DOI":"10.1111\/j.1399-3046.2012.01667.x","article-title":"Evaluation of cardiac manifestations in pediatric liver transplant candidates.","volume":"16","author":"Madan","year":"2012","journal-title":"Pediatr Transpl"},{"key":"R41-40-20250207","doi-asserted-by":"crossref","first-page":"536540","DOI":"10.1111\/j.1399-3046.2007.00845.x","article-title":"Preoperative pulmonary assessment of children for liver transplantation.","volume":"12","author":"Alves","year":"2008","journal-title":"Pediatr Transpl"},{"key":"R42-40-20250207","doi-asserted-by":"crossref","first-page":"171175","DOI":"10.1007\/s12098-010-0216-9","article-title":"Pulmonary evaluation in pediatric liver transplant candidates.","volume":"78","author":"Dehghani","year":"2011","journal-title":"Indian J Pediatr"},{"key":"R43-40-20250207","doi-asserted-by":"crossref","first-page":"e522527","DOI":"10.1542\/peds.2007-1075","article-title":"Prevalence of hepatopulmonary syndrome in children.","volume":"121","author":"Noli","year":"2008","journal-title":"Pediatrics"},{"key":"R44-40-20250207","doi-asserted-by":"crossref","first-page":"192197","DOI":"10.1053\/jhep.2003.50023","article-title":"Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation.","volume":"37","author":"Arguedas","year":"2003","journal-title":"Hepatology"},{"key":"R45-40-20250207","first-page":"10061012","article-title":"(99m)Technetiummacroaggregated albumin perfusion lung scan versus contrast enhanced echocardiography in the diagnosis of the hepatopulmonary syndrome in children with chronic liver disease.","volume":"22","author":"ElShabrawi","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R46-40-20250207","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/j.jpeds.2005.02.019","article-title":"Portopulmonary hypertension in pediatric patients.","volume":"147","author":"Condino","year":"2005","journal-title":"J Pediatr"},{"key":"R47-40-20250207","doi-asserted-by":"crossref","first-page":"15021510","DOI":"10.1002\/hep.21431","article-title":"Portopulmonary hypertension: results from a 10year screening algorithm.","volume":"44","author":"Krowka","year":"2006","journal-title":"Hepatology"},{"key":"R48-40-20250207","doi-asserted-by":"crossref","first-page":"313317","DOI":"10.1136\/thx.52.4.313","article-title":"A prognostic model for the prediction of survival in cystic fibrosis.","volume":"52","author":"Hayllar","year":"1997","journal-title":"Thorax"},{"key":"R49-40-20250207","doi-asserted-by":"crossref","first-page":"585593","DOI":"10.1002\/lt.23389","article-title":"Pulmonary function in individuals who underwent liver transplantation: from the US cystic fibrosis foundation registry.","volume":"18","author":"Miller","year":"2012","journal-title":"Liver Transpl"},{"key":"R50-40-20250207","doi-asserted-by":"crossref","first-page":"24732483","DOI":"10.1056\/NEJMra054415","article-title":"Assessing kidney functionmeasured and estimated glomerular filtration rate.","volume":"354","author":"Stevens","year":"2006","journal-title":"N Engl J Med"},{"key":"R51-40-20250207","doi-asserted-by":"crossref","first-page":"629637","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD.","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R52-40-20250207","doi-asserted-by":"crossref","first-page":"344349","DOI":"10.1002\/lt.20330","article-title":"Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation.","volume":"11","author":"Samyn","year":"2005","journal-title":"Liver Transpl"},{"key":"R53-40-20250207","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/adc.82.1.71","article-title":"Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children.","volume":"82","author":"Finney","year":"2000","journal-title":"Arch Dis Child"},{"key":"R54-40-20250207","first-page":"10281035","article-title":"Modified RIFLE criteria in critically ill children with acute kidney injury.","volume":"71","author":"AkcanArikan","year":"2007","journal-title":"Kidney Int"},{"key":"R55-40-20250207","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1111\/j.1399-3046.2008.01046.x","article-title":"Indications for combined liver and kidney transplantation in children.","volume":"13","author":"Chava","year":"2009","journal-title":"Pediatr Transpl"},{"key":"R57-40-20250207","doi-asserted-by":"crossref","first-page":"26732682","DOI":"10.1111\/j.1600-6143.2010.03316.x","article-title":"Glomerular filtration rate following pediatric liver transplantationthe SPLIT experience.","volume":"10","author":"Campbell","year":"2010","journal-title":"Am J Transpl"},{"key":"R58-40-20250207","first-page":"311316","article-title":"Tyrosinemia: the Quebec experience.","volume":"19","author":"Paradis","year":"1996","journal-title":"Clin Invest Med"},{"key":"R59-40-20250207","doi-asserted-by":"crossref","first-page":"631637","DOI":"10.1097\/00007890-200108270-00012","article-title":"Renal function before and long after liver transplantation in children.","volume":"72","author":"Berg","year":"2001","journal-title":"Transplantation"},{"key":"R60-40-20250207","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1016\/0046-8177(92)90012-R","article-title":"The pathologic spectrum of the nephropathy associated with alpha 1antitrypsin deficiency.","volume":"23","author":"Davis","year":"1992","journal-title":"Hum Pathol"},{"key":"R61-40-20250207","doi-asserted-by":"crossref","first-page":"104108","DOI":"10.1007\/s002470050551","article-title":"The kidney in children with tyrosinemia: sonographic, CT and biochemical findings.","volume":"29","author":"Forget","year":"1999","journal-title":"Pediatr Radiol"},{"key":"R62-40-20250207","doi-asserted-by":"crossref","first-page":"940948","DOI":"10.1002\/lt.23437","article-title":"Outcomes of liver transplantation for patients with alagille syndrome: The studies of pediatric liver transplantation experience.","volume":"18","author":"Kamath","year":"2012","journal-title":"Liver Transpl"},{"key":"R63-40-20250207","doi-asserted-by":"crossref","first-page":"41321","DOI":"10.1111\/j.1365-2125.2009.03461.x","article-title":"Influence of ABCB1 polymorphisms and haplotypes on tacrolimus nephrotoxicity and dosage requirements in children with liver transplant.","volume":"68","author":"Hawwa","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"R64-40-20250207","first-page":"220223","article-title":"Dental findings of children with biliary atresia: report of seven cases.","volume":"57","author":"Morisaki","year":"1990","journal-title":"ASDC J Dent Child"},{"key":"R65-40-20250207","first-page":"474480","article-title":"Oral changes associated with endstage liver disease and liver transplantation: implications for dental management.","volume":"58","author":"Seow","year":"1991","journal-title":"ASDC J Dent Child"},{"key":"R66-40-20250207","doi-asserted-by":"crossref","first-page":"280286","DOI":"10.1002\/lt.21038","article-title":"Dental health status of liver transplant candidates.","volume":"13","author":"Guggenheimer","year":"2007","journal-title":"Liver Transpl"},{"key":"R67-40-20250207","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1111\/j.1752-7325.2008.00092.x","article-title":"Oral disease burden and utilization of dental care patterns among pediatric solid organ transplant recipients.","volume":"69","author":"Shiboski","year":"2009","journal-title":"J Public Health Dent"},{"key":"R68-40-20250207","doi-asserted-by":"crossref","first-page":"66672","DOI":"10.1111\/j.1399-3046.2005.00369.x","article-title":"Anesthetic issues in pediatric liver transplantation.","volume":"9","author":"Yudkowitz","year":"2005","journal-title":"Pediatr Transpl"},{"key":"R69-40-20250207","doi-asserted-by":"crossref","first-page":"809826","DOI":"10.1016\/j.atc.2004.06.005","article-title":"Anesthetic management of the pediatric patient undergoing solid organ transplantation.","volume":"22","author":"Uejima","year":"2004","journal-title":"Anesthesiol Clin North Am"},{"key":"R70-40-20250207","first-page":"23832386","article-title":"Anesthetic risk factors associated with early mortality in pediatric liver transplantation.","volume":"42","author":"CastanedaMartinez","year":"2010","journal-title":"Transpl Proc"},{"key":"R71-40-20250207","doi-asserted-by":"crossref","first-page":"737743","DOI":"10.1002\/lt.23427","article-title":"Anesthesia for liver transplantation in US academic centers: institutional structure and perioperative care.","volume":"18","author":"Walia","year":"2012","journal-title":"Liver Transpl"},{"key":"R72-40-20250207","doi-asserted-by":"crossref","first-page":"652661","DOI":"10.1111\/j.1399-3046.2005.00351.x","article-title":"Immunization of pediatric solidorgan transplantation candidates: immunizations in transplant candidates.","volume":"9","author":"Campbell","year":"2005","journal-title":"Pediatr Transpl"},{"key":"R73-40-20250207","first-page":"5057","article-title":"Successful serologybased intervention to increase protection against vaccinepreventable diseases in livertransplanted children: a 19yr review of the Swiss national reference center.","volume":"16","author":"LHuillier","year":"2012","journal-title":"Pediatr Transpl"},{"key":"R75-40-20250207","doi-asserted-by":"crossref","first-page":"e528530","DOI":"10.1016\/j.ijid.2009.06.013","article-title":"Acute measles infection triggering an episode of liver transplant rejection.","volume":"14","author":"Sternfeld","year":"2010","journal-title":"Int J Infect Dis"},{"key":"R76-40-20250207","doi-asserted-by":"crossref","first-page":"28122815","DOI":"10.1016\/j.vaccine.2009.02.094","article-title":"Humoral immunogenicity to measles, rubella, and varicellazoster vaccines in biliary atresia children.","volume":"27","author":"Wu","year":"2009","journal-title":"Vaccine"},{"key":"R77-40-20250207","doi-asserted-by":"crossref","first-page":"543550","DOI":"10.1097\/00007890-200208270-00020","article-title":"Efficacy and safety of immunization for pre and postliver transplant children.","volume":"74","author":"Kano","year":"2002","journal-title":"Transplantation"},{"key":"R78-40-20250207","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11894-012-0300-6","article-title":"Immunizations in chronic liver disease: what should be done and what is the evidence.","volume":"15","author":"Leise","year":"2013","journal-title":"Curr Gastroenterol Rep"},{"key":"R79-40-20250207","doi-asserted-by":"crossref","first-page":"113115","DOI":"10.1001\/archinte.160.1.113","article-title":"Hepatic decompensation in patients with cirrhosis during infection with influenza A.","volume":"160","author":"Duchini","year":"2000","journal-title":"Arch Intern Med"},{"key":"R80-40-20250207","doi-asserted-by":"crossref","first-page":"159163","DOI":"10.1016\/j.jcv.2007.04.018","article-title":"Clinical impact of influenza immunization in patients with liver cirrhosis.","volume":"39","author":"Song","year":"2007","journal-title":"J Clin Virol"},{"issue":"Suppl 4","key":"R81-40-20250207","first-page":"S258262","article-title":"Guidelines for vaccination of solid organ transplant candidates and recipients.","volume":"9","author":"DanzingerIsakov","year":"2009","journal-title":"Am J Transpl"},{"key":"R82-40-20250207","doi-asserted-by":"crossref","first-page":"309318","DOI":"10.1093\/cid\/cit816","article-title":"2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host.","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R83-40-20250207","doi-asserted-by":"crossref","first-page":"857869","DOI":"10.1086\/313823","article-title":"Immunization of pediatric solid organ transplant candidates and recipients.","volume":"30","author":"Burroughs","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"257","key":"R84-40-20250207","first-page":"13351340","article-title":"Vaccineassociated paralytic poliomyelitis. United States: 1973 through 1984.","author":"Nkowane","year":"1987","journal-title":"JAMA"},{"key":"R86-40-20250207","doi-asserted-by":"crossref","first-page":"730740","DOI":"10.1002\/lt.23659","article-title":"Decreasing incidence of symptomatic EpsteinBarr virus disease and posttransplant lymphoproliferative disorder in pediatric liver transplant recipients: report of the studies of pediatric liver transplantation experience.","volume":"19","author":"Narkewicz","year":"2013","journal-title":"Liver Transpl"},{"key":"R87-40-20250207","doi-asserted-by":"crossref","first-page":"779795","DOI":"10.1097\/TP.0b013e3181cee42f","article-title":"International consensus guidelines on the management of cytomegalovirus in solid organ transplantation.","volume":"89","author":"Kotton","year":"2010","journal-title":"Transplantation"},{"key":"R88-40-20250207","first-page":"453458","article-title":"Living with chronic pediatric liver disease: the parents experience.","volume":"18","author":"Simon","year":"1992","journal-title":"Pediatr Nurs"},{"key":"R89-40-20250207","doi-asserted-by":"crossref","first-page":"141146","DOI":"10.1542\/peds.2012-0567","article-title":"Parental refusal of a liver transplant for a child with biliary atresia.","volume":"131","author":"Cronin","year":"2013","journal-title":"Pediatrics"},{"key":"R90-40-20250207","doi-asserted-by":"crossref","first-page":"54545456","DOI":"10.1200\/JCO.2006.06.4709","article-title":"Do parents have the right to refuse standard treatment for their child with favorableprognosis cancer? Ethical and legal concerns.","volume":"24","author":"Hord","year":"2006","journal-title":"J Clin Oncol"},{"key":"R91-40-20250207","doi-asserted-by":"crossref","first-page":"656660","DOI":"10.1111\/j.1399-3046.2007.00864.x","article-title":"Preliminary quantitative investigation of predictors of treatment nonadherence in pediatric transplantation: a brief report.","volume":"12","author":"Kahana","year":"2008","journal-title":"Pediatr Transpl"},{"key":"R92-40-20250207","doi-asserted-by":"crossref","first-page":"200206","DOI":"10.1034\/j.1399-3046.2000.00110.x","article-title":"Nonadherence in pediatric liver transplant recipientsan assessment of risk factors and natural history.","volume":"4","author":"Lurie","year":"2000","journal-title":"Pediatr Transpl"},{"key":"R93-40-20250207","doi-asserted-by":"crossref","first-page":"489493","DOI":"10.1046\/j.1397-3142.2003.00117.x","article-title":"A typology of nonadherence in pediatric renal transplant recipients.","volume":"7","author":"Shaw","year":"2003","journal-title":"Pediatr Transpl"},{"key":"R94-40-20250207","doi-asserted-by":"crossref","first-page":"142147","DOI":"10.1111\/j.1399-3046.2010.01428.x","article-title":"Interrater reliability of the Pediatric Transplant Rating Instrument (PTRI): challenges to reliably identifying adherence risk factors during pediatric pretransplant evaluations.","volume":"15","author":"Fisher","year":"2011","journal-title":"Pediatr Transpl"},{"key":"R95-40-20250207","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.1111\/j.1399-3046.2007.00785.x","article-title":"Pediatric Transplant Rating Instrument a scale for the pretransplant psychiatric evaluation of pediatric organ transplant recipients.","volume":"12","author":"Fung","year":"2008","journal-title":"Pediatr Transpl"},{"key":"R96-40-20250207","doi-asserted-by":"crossref","first-page":"352365","DOI":"10.1177\/1359104599004003006","article-title":"Pediatric psychiatric pretransplant evaluation.","volume":"4","author":"Shaw","year":"1999","journal-title":"Clin Child Psychol Psychiatry"},{"key":"R97-40-20250207","doi-asserted-by":"crossref","first-page":"522525","DOI":"10.1097\/MOT.0b013e3283307a62","article-title":"Cognitive development following pediatric solid organ transplantation.","volume":"14","author":"Alonso","year":"2009","journal-title":"Curr Opin Organ Transpl"},{"key":"R98-40-20250207","doi-asserted-by":"crossref","first-page":"12521256","DOI":"10.1097\/01.TP.0000161251.20520.42","article-title":"Cognitive abilities in children after liver transplantation.","volume":"79","author":"Kaller","year":"2005","journal-title":"Transplantation"},{"key":"R99-40-20250207","doi-asserted-by":"crossref","first-page":"303311","DOI":"10.1111\/j.1600-6143.2010.03363.x","article-title":"Cognitive and academic outcomes after pediatric liver transplantation: Functional Outcomes Group (FOG) results.","volume":"11","author":"Sorensen","year":"2011","journal-title":"Am J Transpl"},{"key":"R100-40-20250207","doi-asserted-by":"crossref","first-page":"111118","DOI":"10.1034\/j.1399-3046.2003.00026.x","article-title":"Neurocognitive outcome in pediatric liver transplant recipients.","volume":"7","author":"Krull","year":"2003","journal-title":"Pediatr Transpl"},{"key":"R101-40-20250207","doi-asserted-by":"crossref","first-page":"16941695","DOI":"10.1016\/j.transproceed.2006.05.036","article-title":"Neurodevelopmental outcomes of infant multivisceral transplant recipients: a longitudinal study.","volume":"38","author":"Thevenin","year":"2006","journal-title":"Transpl Proc"},{"key":"R102-40-20250207","doi-asserted-by":"crossref","first-page":"12361240","DOI":"10.1097\/01.TP.0000062843.10397.32","article-title":"Cognitive performance of children who have undergone liver transplantation.","volume":"75","author":"Schulz","year":"2003","journal-title":"Transplantation"},{"key":"R103-40-20250207","doi-asserted-by":"crossref","first-page":"894898","DOI":"10.1016\/S0022-3476(97)70039-8","article-title":"Neurodevelopmental outcome of young children with extrahepatic biliary atresia 1 year after liver transplantation.","volume":"131","author":"Wayman","year":"1997","journal-title":"J Pediatr"},{"key":"R104-40-20250207","doi-asserted-by":"crossref","first-page":"384389","DOI":"10.1097\/MPG.0b013e318259ed20","article-title":"Developmental assessment of infants with biliary atresia: differences between boys and girls.","volume":"55","author":"Caudle","year":"2012","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R106-40-20250207","doi-asserted-by":"crossref","first-page":"843850","DOI":"10.1111\/j.1399-3046.2008.01072.x","article-title":"Use of neurodevelopmental delay in pediatric solid organ transplant listing decisions: inconsistencies in standards across major pediatric transplant centers.","volume":"13","author":"Richards","year":"2009","journal-title":"Pediatr Transpl"},{"key":"R107-40-20250207","doi-asserted-by":"crossref","first-page":"518257","DOI":"10.1053\/j.ajkd.2005.11.015","article-title":"Kidney transplantation in pediatric recipients with mental retardation: clinical results of a multicenter experience in Japan.","volume":"47","author":"Ohta","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"R108-40-20250207","first-page":"431438","article-title":"Livingrelated liver transplantation.","volume":"33","author":"Lacaille","year":"2001","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R109-40-20250207","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1034\/j.1399-3046.2002.1r072.x","article-title":"Livingdonor liver transplantation in children.","volume":"6","author":"Emre","year":"2002","journal-title":"Pediatr Transpl"},{"key":"R110-40-20250207","first-page":"155159","article-title":"Good Samaritan liver donor in Pediatr Transpl Pediatr T","volume":"13","author":"JeanBernard","year":"2009","journal-title":"ranspl"},{"key":"R111-40-20250207","doi-asserted-by":"crossref","first-page":"10321035","DOI":"10.1111\/j.1600-6143.2006.01725.x","article-title":"Living anonymous liver donation: case report and ethical justification.","volume":"7","author":"Wright","year":"2007","journal-title":"Am J Transpl"},{"key":"R112-40-20250207","doi-asserted-by":"crossref","first-page":"235240","DOI":"10.1016\/S0033-3182(93)71885-X","article-title":"Liver transplantation using living donors. Preliminary donor psychiatric outcomes.","volume":"34","author":"Goldman","year":"1993","journal-title":"Psychosomatics"},{"key":"R113-40-20250207","doi-asserted-by":"crossref","first-page":"890895","DOI":"10.1053\/jlts.2001.27963","article-title":"Living donor liver transplantation for children with liver failure and concurrent multiple organ system failure.","volume":"7","author":"Mack","year":"2001","journal-title":"Liver Transpl"},{"key":"R114-40-20250207","doi-asserted-by":"crossref","first-page":"27542763","DOI":"10.1111\/j.1600-6143.2005.01084.x","article-title":"Living donor liver transplantation for pediatric patients with inheritable metabolic disorders.","volume":"5","author":"Morioka","year":"2005","journal-title":"Am J Transpl"},{"key":"R115-40-20250207","doi-asserted-by":"crossref","first-page":"28752877","DOI":"10.1016\/j.transproceed.2009.07.025","article-title":"Living related liver transplantation in CriglerNajjar syndrome type 1.","volume":"41","author":"Ozcay","year":"2009","journal-title":"Transpl Proc"},{"key":"R116-40-20250207","first-page":"286288","article-title":"Equal outcome of livingrelated liver transplantation for Wilsons disease from heterozygote and nonheterozygote donors: a report of a brother and sister.","volume":"61","author":"ElKaraksy","year":"2007","journal-title":"Indian J Med Sci"},{"key":"R117-40-20250207","doi-asserted-by":"crossref","first-page":"409410","DOI":"10.1111\/j.1442-200X.2009.02831.x","article-title":"Early neonatal onset carbamoylphosphate synthase 1 deficiency treated with continuous hemodiafiltration and early livingrelated liver transplantation.","volume":"51","author":"Ishida","year":"2009","journal-title":"Pediatr Int"},{"key":"R118-40-20250207","doi-asserted-by":"crossref","first-page":"205210","DOI":"10.1023\/B:BOLI.0000028778.54210.13","article-title":"Livingdonor liver transplantation for propionic acidaemia.","volume":"27","author":"Yorifuji","year":"2004","journal-title":"J Inherit Metabol Dis"},{"key":"R119-40-20250207","doi-asserted-by":"crossref","first-page":"453456","DOI":"10.1097\/MPG.0b013e3180ca8720","article-title":"Living related liver transplant in a patient with argininosuccinic aciduria and cirrhosis: metabolic followup.","volume":"46","author":"Marble","year":"2008","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R120-40-20250207","doi-asserted-by":"crossref","first-page":"570574","DOI":"10.1111\/j.1399-3046.2006.00524.x","article-title":"Safety of livingrelated liver transplantation for progressive familial intrahepatic cholestasis.","volume":"10","author":"Cutillo","year":"2006","journal-title":"Pediatr Transpl"},{"key":"R121-40-20250207","doi-asserted-by":"crossref","first-page":"161164","DOI":"10.1016\/j.transproceed.2010.11.013","article-title":"Living related donor liver transplantation in children.","volume":"43","author":"Tannuri","year":"2011","journal-title":"Transpl Proc"},{"key":"R122-40-20250207","doi-asserted-by":"crossref","first-page":"21472150","DOI":"10.1097\/01.TP.0000066804.33006.17","article-title":"Livingrelated liver transplantation for Alagille syndrome.","volume":"75","author":"Kasahara","year":"2003","journal-title":"Transplantation"},{"key":"R123-40-20250207","doi-asserted-by":"crossref","first-page":"17041713","DOI":"10.1016\/S0140-6736(09)60946-6","article-title":"Biliary atresia.","volume":"374","author":"Hartley","year":"2009","journal-title":"Lancet"},{"key":"R124-40-20250207","doi-asserted-by":"crossref","first-page":"111116","DOI":"10.1055\/s-2008-1038479","article-title":"European biliary atresia registries: summary of a symposium.","volume":"18","author":"Petersen","year":"2008","journal-title":"Eur J Pediatr Surgery"},{"key":"R125-40-20250207","doi-asserted-by":"crossref","first-page":"575581","DOI":"10.1016\/j.jpedsurg.2003.12.014","article-title":"The outcome of the older ( or 100 days) infant with biliary atresia.","volume":"39","author":"Davenport","year":"2004","journal-title":"J Pediatr Surg"},{"key":"R126-40-20250207","doi-asserted-by":"crossref","first-page":"566581","DOI":"10.1002\/hep.21790","article-title":"Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop.","volume":"46","author":"Sokol","year":"2007","journal-title":"Hepatology"},{"key":"R127-40-20250207","doi-asserted-by":"crossref","first-page":"393400","DOI":"10.1016\/j.jpeds.2006.05.030","article-title":"The biliary atresia splenic malformation syndrome: a 28year singlecenter retrospective study.","volume":"149","author":"Davenport","year":"2006","journal-title":"J Pediatr"},{"key":"R128-40-20250207","doi-asserted-by":"crossref","first-page":"467474","DOI":"10.1016\/j.jpeds.2005.12.054","article-title":"A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000.","volume":"148","author":"Shneider","year":"2006","journal-title":"J Pediatr"},{"key":"R129-40-20250207","doi-asserted-by":"crossref","first-page":"694698","DOI":"10.1097\/SLA.0b013e3181638627","article-title":"Surgical outcome in biliary atresia: etiology affects the influence of age at surgery.","volume":"247","author":"Davenport","year":"2008","journal-title":"Ann Surg"},{"key":"R130-40-20250207","doi-asserted-by":"crossref","first-page":"11961198","DOI":"10.1053\/jpsu.2001.25761","article-title":"Kasai portoenterostomy: differences related to race.","volume":"36","author":"Lee","year":"2001","journal-title":"J Pediatr Surg"},{"key":"R131-40-20250207","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1053\/jpsu.2001.20020","article-title":"The Kasai portoenterostomy: when is it too late?","volume":"36","author":"Schoen","year":"2001","journal-title":"J Pediatr Surg"},{"key":"R132-40-20250207","doi-asserted-by":"crossref","first-page":"10861091","DOI":"10.1016\/j.cgh.2011.07.024","article-title":"Twentyyear transplantfree survival rate among patients with biliary atresia.","volume":"9","author":"de Vries","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R133-40-20250207","first-page":"344354","article-title":"International incidence and outcomes of biliary atresia.","volume":"56","author":"JimenezRivera","year":"2013","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R134-40-20250207","doi-asserted-by":"crossref","first-page":"180183","DOI":"10.1055\/s-2007-965147","article-title":"Surgery for biliary atresiais there a European consensus?","volume":"17","author":"Davenport","year":"2007","journal-title":"Eur J Pediatr Surg"},{"key":"R135-40-20250207","doi-asserted-by":"crossref","first-page":"13211327","DOI":"10.1016\/j.jpedsurg.2007.11.043","article-title":"Review of historical cohort: ursodeoxycholic acid in extrahepatic biliary atresia.","volume":"43","author":"Kotb","year":"2008","journal-title":"J Pediatr Surg"},{"key":"R136-40-20250207","doi-asserted-by":"crossref","first-page":"440444","DOI":"10.1155\/2011\/125610","article-title":"Does adjuvant steroid therapy postKasai portoenterostomy improve outcome of biliary atresia? Systematic review and metaanalysis.","volume":"25","author":"Sarkhy","year":"2011","journal-title":"Can J Gastroenterol"},{"key":"R137-40-20250207","doi-asserted-by":"crossref","first-page":"590593","DOI":"10.1053\/jpsu.2003.50128","article-title":"Prophylactic oral antibiotics in prevention of recurrent cholangitis after the Kasai portoenterostomy.","volume":"38","author":"Bu","year":"2003","journal-title":"J Pediatr Surg"},{"key":"R138-40-20250207","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s12519-008-0003-0","article-title":"Current concept about postoperative cholangitis in biliary atresia.","volume":"4","author":"Luo","year":"2008","journal-title":"World J Pediatr"},{"key":"R139-40-20250207","first-page":"263A","article-title":"Highdose corticosteroid therapy following portoenterostomy in infants with biliary atresia does not improve outcome: the mulitcenter, randomized, doubleblind, placebocontrolled START Trial.","volume":"58","author":"Bezerra","year":"2013","journal-title":"Hepatology"},{"key":"R140-40-20250207","doi-asserted-by":"crossref","first-page":"180185","DOI":"10.1016\/j.jpeds.2005.04.073","article-title":"Biliary atresia: clinical profiles, risk factors, and outcomes of 755 patients listed for liver transplantation.","volume":"147","author":"Utterson","year":"2005","journal-title":"J Pediatr"},{"key":"R141-40-20250207","doi-asserted-by":"crossref","first-page":"8994","DOI":"10.1097\/01.mpg.0000226378.03247.1f","article-title":"Impact of pretransplant growth retardation in pediatric liver transplantation.","volume":"43","author":"Barshes","year":"2006","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R142-40-20250207","doi-asserted-by":"crossref","first-page":"117119","DOI":"10.1111\/j.1399-3046.2006.00623.x","article-title":"Early occurrence of hepatocellular carcinoma in biliary atresia treated by liver transplantation.","volume":"11","author":"Brunati","year":"2007","journal-title":"Pediatr Transpl"},{"key":"R143-40-20250207","doi-asserted-by":"crossref","first-page":"819821","DOI":"10.1016\/j.jpedsurg.2012.01.020","article-title":"Hepatocellular carcinoma in an infant with biliary atresia younger than 1 year.","volume":"47","author":"Kim","year":"2012","journal-title":"J Pediatr Surg"},{"key":"R144-40-20250207","doi-asserted-by":"crossref","first-page":"573579","DOI":"10.1111\/j.1399-3046.2011.01528.x","article-title":"Favorable outcome of primary liver transplantation in children with cirrhosis and hepatocellular carcinoma.","volume":"15","author":"Romano","year":"2011","journal-title":"Pediatr Transpl"},{"key":"R145-40-20250207","doi-asserted-by":"crossref","first-page":"21652168","DOI":"10.1016\/j.jpedsurg.2008.08.039","article-title":"Prognostic implications of bile lakes after surgery for biliary atresia.","volume":"43","author":"Inoue","year":"2008","journal-title":"J Pediatr Surg"},{"key":"R146-40-20250207","doi-asserted-by":"crossref","first-page":"11931200","DOI":"10.1002\/lt.20509","article-title":"Orthotopic liver transplantation for biliary atresia: the U.S. experience.","volume":"11","author":"Barshes","year":"2005","journal-title":"Liver Transpl"},{"key":"R147-40-20250207","doi-asserted-by":"crossref","first-page":"195200","DOI":"10.1016\/S0022-3476(87)80153-1","article-title":"Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): review of 80 cases.","volume":"110","author":"Alagille","year":"1987","journal-title":"J Pediatr"},{"key":"R148-40-20250207","doi-asserted-by":"crossref","first-page":"243251","DOI":"10.1038\/ng0797-243","article-title":"Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1.","volume":"16","author":"Li","year":"1997","journal-title":"Nat Genet"},{"key":"R149-40-20250207","doi-asserted-by":"crossref","first-page":"235242","DOI":"10.1038\/ng0797-235","article-title":"Mutations in the human Jagged1 gene are responsible for Alagille syndrome.","volume":"16","author":"Oda","year":"1997","journal-title":"Nat Genet"},{"key":"R150-40-20250207","first-page":"459466","article-title":"Arteriohepatic dysplasia: familial pulmonary arterial stenosis with neonatal liver disease.","volume":"48","author":"Watson","year":"1973","journal-title":"Arch Dis Child"},{"key":"R151-40-20250207","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/MPG.0b013e3181c1601f","article-title":"Alagille syndrome and liver transplantation.","volume":"50","author":"Kamath","year":"2010","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R152-40-20250207","doi-asserted-by":"crossref","first-page":"822829","DOI":"10.1002\/hep.510290331","article-title":"Features of Alagille syndrome in 92 patients: frequency and relation to prognosis.","volume":"29","author":"Emerick","year":"1999","journal-title":"Hepatology"},{"key":"R153-40-20250207","doi-asserted-by":"crossref","first-page":"220224","DOI":"10.1016\/S0022-3476(95)70298-9","article-title":"Outcome of syndromic paucity of interlobular bile ducts (Alagille syndrome) with onset of cholestasis in infancy.","volume":"127","author":"Hoffenberg","year":"1995","journal-title":"J Pediatr"},{"key":"R154-40-20250207","first-page":"431437","article-title":"Variable morbidity in alagille syndrome: a review of 43 cases.","volume":"29","author":"QuirosTejeira","year":"1999","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R155-40-20250207","doi-asserted-by":"crossref","first-page":"431435","DOI":"10.1136\/gut.49.3.431","article-title":"Outcome of liver disease in children with Alagille syndrome: a study of 163 patients.","volume":"49","author":"Lykavieris","year":"2001","journal-title":"Gut"},{"key":"R156-40-20250207","doi-asserted-by":"crossref","first-page":"154158","DOI":"10.1111\/j.1399-3046.2005.00432.x","article-title":"Liver transplantation in children with Alagille syndrome: indications and outcome.","volume":"10","author":"Englert","year":"2006","journal-title":"Pediatr Transpl"},{"key":"R157-40-20250207","doi-asserted-by":"crossref","first-page":"345347","DOI":"10.1097\/00007890-200107270-00034","article-title":"Elevated right ventricular pressures are not a contraindication to liver transplantation in Alagille syndrome.","volume":"72","author":"Ovaert","year":"2001","journal-title":"Transplantation"},{"key":"R158-40-20250207","first-page":"14531456","article-title":"Partial internal biliary diversion for Alagille syndrome: case report and review of the literature.","volume":"47","author":"SheflinFindling","year":"2012","journal-title":"J Pediatr Surg"},{"key":"R159-40-20250207","doi-asserted-by":"crossref","first-page":"216221","DOI":"10.1097\/MPG.0b013e31819a4e3d","article-title":"Partial external biliary diversion in children with progressive familial intrahepatic cholestasis and Alagille disease.","volume":"49","author":"Yang","year":"2009","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R160-40-20250207","doi-asserted-by":"crossref","first-page":"800805","DOI":"10.1016\/j.jpedsurg.2006.12.032","article-title":"Ileal exclusion for refractory symptomatic cholestasis in Alagille syndrome.","volume":"42","author":"Modi","year":"2007","journal-title":"J Pediatr Surg"},{"key":"R161-40-20250207","doi-asserted-by":"crossref","first-page":"580586","DOI":"10.1097\/MPG.0b013e3181d98ea8","article-title":"Medical management of Alagille syndrome.","volume":"50","author":"Kamath","year":"2010","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R162-40-20250207","doi-asserted-by":"crossref","first-page":"13541358","DOI":"10.1161\/01.CIR.0000121361.01862.A4","article-title":"Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality.","volume":"109","author":"Kamath","year":"2004","journal-title":"Circulation"},{"key":"R163-40-20250207","doi-asserted-by":"crossref","first-page":"823828","DOI":"10.1097\/00007890-200109150-00014","article-title":"Hemodynamic response to continuous infusion of dobutamine in Alagilles syndrome.","volume":"72","author":"Razavi","year":"2001","journal-title":"Transplantation"},{"key":"R164-40-20250207","doi-asserted-by":"crossref","first-page":"622628","DOI":"10.1111\/j.1399-3046.2009.01286.x","article-title":"Orthotopic liver transplantation for children with Alagille syndrome.","volume":"14","author":"Arnon","year":"2010","journal-title":"Pediatr Transpl"},{"key":"R165-40-20250207","first-page":"10281034","article-title":"Harambat J, Ranchin B, Dubourg L, Liutkus A, HadjHaissa A, Rivet C, Boillot O, Lachaux A, Cochat P. Renal function in pediatric liver transplantation: a longterm followup study.","volume":"86","author":"Hori","year":"2008","journal-title":"Transplantation"},{"key":"R166-40-20250207","doi-asserted-by":"crossref","first-page":"20892111","DOI":"10.1002\/hep.22261","article-title":"Diagnosis and treatment of Wilson disease: an update.","volume":"47","author":"Roberts","year":"2008","journal-title":"Hepatology"},{"key":"R168-40-20250207","doi-asserted-by":"crossref","first-page":"652658","DOI":"10.1016\/j.jpeds.2005.12.051","article-title":"Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group.","volume":"148","author":"Squires","year":"2006","journal-title":"J Pediatr"},{"key":"R169-40-20250207","doi-asserted-by":"crossref","first-page":"15421549","DOI":"10.1002\/hep.26001","article-title":"Intravenous Nacetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebocontrolled clinical trial.","volume":"57","author":"Squires","year":"2013","journal-title":"Hepatology"},{"key":"R170-40-20250207","doi-asserted-by":"crossref","first-page":"575581","DOI":"10.1097\/01.MPG.0000158524.30294.E2","article-title":"Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United kingdom.","volume":"40","author":"Lee","year":"2005","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R171-40-20250207","first-page":"9396","article-title":"Herpes simplex virus hepatitis its high time we consider empiric treatment.","volume":"20","author":"Navaneethan","year":"2011","journal-title":"J Gastrointest Liver Dis"},{"key":"R172-40-20250207","doi-asserted-by":"crossref","first-page":"566571","DOI":"10.1016\/j.jpeds.2009.04.012","article-title":"Treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin.","volume":"155","author":"Rand","year":"2009","journal-title":"J Pediatr"},{"key":"R173-40-20250207","doi-asserted-by":"crossref","first-page":"541547","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20year experience.","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology"},{"key":"R174-40-20250207","doi-asserted-by":"crossref","first-page":"14011415","DOI":"10.1002\/hep.22177","article-title":"Acute liver failure: summary of a workshop.","volume":"47","author":"Lee","year":"2008","journal-title":"Hepatology"},{"key":"R175-40-20250207","doi-asserted-by":"crossref","first-page":"849852","DOI":"10.1136\/gut.48.6.849","article-title":"Wilsons disease with severe hepatic insufficiency: beneficial effects of early administration of Dpenicillamine.","volume":"48","author":"Durand","year":"2001","journal-title":"Gut"},{"key":"R176-40-20250207","doi-asserted-by":"crossref","first-page":"801806","DOI":"10.1016\/j.jpeds.2009.06.005","article-title":"Pattern of diagnostic evaluation for the causes of pediatric acute liver failure: an opportunity for quality improvement.","volume":"155","author":"Narkewicz","year":"2009","journal-title":"J Pediatr"},{"key":"R177-40-20250207","doi-asserted-by":"crossref","first-page":"10101016","DOI":"10.1016\/j.jpeds.2012.11.021","article-title":"Evaluation of the liver injury unit scoring system to predict survival in a multinational study of pediatric acute liver failure.","volume":"162","author":"Lu","year":"2013","journal-title":"J Pediatr"},{"key":"R178-40-20250207","doi-asserted-by":"crossref","first-page":"319323","DOI":"10.1016\/j.jpeds.2012.07.002","article-title":"Kings College Hospital Criteria for nonacetaminophen induced acute liver failure in an international cohort of children.","volume":"162","author":"Sundaram","year":"2013","journal-title":"J Pediatr"},{"key":"R179-40-20250207","doi-asserted-by":"crossref","first-page":"802807","DOI":"10.1016\/j.jpeds.2010.10.033","article-title":"Valproic acidassociated acute liver failure in children: case report and analysis of liver transplantation outcomes in the United States.","volume":"158","author":"Mindikoglu","year":"2011","journal-title":"J Pediatr"},{"key":"R180-40-20250207","doi-asserted-by":"crossref","first-page":"748752","DOI":"10.1111\/ped.12181","article-title":"Differential clinical characteristics of acute liver failure caused by hemophagocytic lymphohistiocytosis in children.","volume":"55","author":"Ryu","year":"2013","journal-title":"Pediatr Int"},{"key":"R181-40-20250207","doi-asserted-by":"crossref","first-page":"12701275","DOI":"10.1002\/pbc.23301","article-title":"Initial liver transplantation for unresectable hepatoblastoma after chemotherapy.","volume":"57","author":"Hery","year":"2011","journal-title":"Pediatr Blood Canc"},{"key":"R182-40-20250207","first-page":"17171723","article-title":"Treatment of hepatoblastoma: the North American cooperative group experience.","volume":"4","author":"Malogolowkin","year":"2012","journal-title":"Front Biosci (Elite Ed)"},{"key":"R183-40-20250207","doi-asserted-by":"crossref","first-page":"7483","DOI":"10.1002\/pbc.10376","article-title":"Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL1 and review of the world experience.","volume":"42","author":"Otte","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"R184-40-20250207","doi-asserted-by":"crossref","first-page":"12451252","DOI":"10.1200\/JCO.2005.07.145","article-title":"Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL1 study.","volume":"23","author":"Aronson","year":"2005","journal-title":"J Clin Oncol"},{"key":"R185-40-20250207","doi-asserted-by":"crossref","first-page":"10131018","DOI":"10.1002\/pbc.22893","article-title":"Critical review of controversial issues in the management of advanced pediatric liver tumors.","volume":"56","author":"Gupta","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R186-40-20250207","doi-asserted-by":"crossref","first-page":"19761983","DOI":"10.1002\/cncr.25722","article-title":"Successful nontransplant resection of POSTTEXT III and IV hepatoblastoma.","volume":"117","author":"Lautz","year":"2011","journal-title":"Cancer"},{"key":"R187-40-20250207","doi-asserted-by":"crossref","first-page":"182186","DOI":"10.1016\/j.jpedsurg.2005.10.091","article-title":"3rd, ONeill JA Jr, Pinson CW, et al. Liver transplantation for childhood hepatic malignancy: a review of the United Network for Organ Sharing (UNOS) database.","volume":"41","author":"Austin","year":"2006","journal-title":"J Pediatr Surg"},{"key":"R188-40-20250207","doi-asserted-by":"crossref","first-page":"13311339","DOI":"10.1016\/j.jpedsurg.2011.11.073","article-title":"Changing treatment and outcome of children with hepatoblastoma: analysis of a single center experience over the last 20 years.","volume":"47","author":"Ismail","year":"2012","journal-title":"J Pediatr Surg"},{"key":"R189-40-20250207","doi-asserted-by":"crossref","first-page":"646650","DOI":"10.1111\/j.1399-3046.2010.01312.x","article-title":"High survival rates after liver transplantation for hepatoblastoma and hepatocellular carcinoma.","volume":"14","author":"Kosola","year":"2010","journal-title":"Pediatr Transpl"},{"key":"R190-40-20250207","first-page":"12931302","article-title":"Liver transplantation in the management of unresectable hepatoblastoma in children.","volume":"4","author":"Meyers","year":"2012","journal-title":"Front Biosci (Elite Ed)"},{"key":"R191-40-20250207","doi-asserted-by":"crossref","first-page":"397399","DOI":"10.1016\/j.jpeds.2003.11.022","article-title":"The development of hepatocellular carcinoma among prospectively followed children with chronic hepatitis B virus infection.","volume":"144","author":"Wen","year":"2004","journal-title":"J Pediatr"},{"key":"R192-40-20250207","doi-asserted-by":"crossref","first-page":"682692","DOI":"10.1111\/j.1399-3046.2009.01062.x","article-title":"Liver transplantation in children with hepatocellular carcinoma. Do Milan criteria apply to pediatric patients?","volume":"13","author":"Ismail","year":"2009","journal-title":"Pediatr Transpl"},{"key":"R193-40-20250207","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1007\/s00268-005-7965-z","article-title":"Clinical characteristics and prognosis of pediatric hepatocellular carcinoma.","volume":"30","author":"Yu","year":"2006","journal-title":"World J Surg"},{"key":"R195-40-20250207","doi-asserted-by":"crossref","first-page":"385390","DOI":"10.1055\/s-2006-951606","article-title":"Serum markers of hepatocellular carcinoma.","volume":"26","author":"Spangenberg","year":"2006","journal-title":"Semin Liver Dis"},{"issue":"Suppl 2","key":"R196-40-20250207","first-page":"S4457","article-title":"Milan criteria in liver transplantation for hepatocellular carcinoma: an evidencebased analysis of 15 years of experience.","volume":"17","author":"Mazzaferro","year":"2011","journal-title":"Liver Transpl"},{"key":"R197-40-20250207","doi-asserted-by":"crossref","first-page":"655660","DOI":"10.1111\/j.1399-3046.2007.00751.x","article-title":"Outcomes of transplantation in children with primary hepatic malignancy.","volume":"11","author":"Beaunoyer","year":"2007","journal-title":"Pediatr Transpl"},{"key":"R199-40-20250207","doi-asserted-by":"crossref","first-page":"165170","DOI":"10.1016\/j.jpedsurg.2011.10.037","article-title":"Lessons from a liver hemangioma registry: subtype classification.","volume":"47","author":"Kulungowski","year":"2012","journal-title":"J Pediatr Surg"},{"key":"R200-40-20250207","doi-asserted-by":"crossref","first-page":"185189","DOI":"10.1056\/NEJM200007203430305","article-title":"Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas.","volume":"343","author":"Huang","year":"2000","journal-title":"N Engl J Med"},{"key":"R201-40-20250207","doi-asserted-by":"crossref","first-page":"22392243","DOI":"10.1016\/j.jpedsurg.2011.09.007","article-title":"Critical infantile hepatic hemangioma: results of a nationwide survey by the Japanese Infantile Hepatic Hemangioma Study Group.","volume":"46","author":"Kuroda","year":"2011","journal-title":"J Pediatr Surg"},{"key":"R202-40-20250207","doi-asserted-by":"crossref","first-page":"8284","DOI":"10.1111\/j.1442-200X.2006.02162.x","article-title":"Successful treatment with vincristine of an infant with intractable KasabachMerritt syndrome.","volume":"48","author":"Taki","year":"2006","journal-title":"Pediatr Int"},{"key":"R203-40-20250207","doi-asserted-by":"crossref","first-page":"567569","DOI":"10.1097\/00043426-199811000-00012","article-title":"KasabachMerritt syndrome associated kaposiform hemangioendothelioma successfully treated with cyclophosphamide, vincristine, and actinomycin D.","volume":"20","author":"Hu","year":"1998","journal-title":"J Pediatr Hematol Oncol"},{"issue":"Suppl 2","key":"R204-40-20250207","first-page":"S2936","article-title":"Best practice guidance for the diagnosis and management of cystic fibrosisassociated liver disease.","volume":"10","author":"Debray","year":"2011","journal-title":"J Cystic Fibrosis"},{"key":"R205-40-20250207","doi-asserted-by":"crossref","first-page":"13741382","DOI":"10.1002\/hep.1840360613","article-title":"Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome.","volume":"36","author":"Colombo","year":"2002","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"R206-40-20250207","first-page":"S113","article-title":"Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group.","volume":"28","author":"Sokol","year":"1999","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R207-40-20250207","doi-asserted-by":"crossref","first-page":"924930","DOI":"10.1002\/hep.1840160412","article-title":"Ursodeoxycholic acid therapy in cystic fibrosisassociated liver disease: a doseresponse study.","volume":"16","author":"Colombo","year":"1992","journal-title":"Hepatology"},{"key":"R208-40-20250207","first-page":"14841490","article-title":"Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a doubleblind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis.","volume":"23","author":"Colombo","year":"1996","journal-title":"Hepatology"},{"key":"R209-40-20250207","doi-asserted-by":"crossref","first-page":"858864","DOI":"10.1097\/MCG.0b013e31819e8bbd","article-title":"Hepatobiliary abnormalities and disease in cystic fibrosis: epidemiology and outcomes through adulthood.","volume":"43","author":"Bhardwaj","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"R210-40-20250207","doi-asserted-by":"crossref","first-page":"15221526","DOI":"10.1002\/lt.20465","article-title":"Variceal hemorrhage and cystic fibrosis: outcomes and implications for liver transplantation.","volume":"11","author":"Gooding","year":"2005","journal-title":"Liver Transpl"},{"key":"R211-40-20250207","doi-asserted-by":"crossref","first-page":"9397","DOI":"10.1034\/j.1399-3046.2003.00021.x","article-title":"Liver transplantation for cholestasis associated with cystic fibrosis in the pediatric population.","volume":"7","author":"Molmenti","year":"2003","journal-title":"Pediatr Transpl"},{"key":"R213-40-20250207","doi-asserted-by":"crossref","first-page":"187188","DOI":"10.1038\/nrgastro.2011.39","article-title":"Liver: Benefit of liver transplantation in patients with cystic fibrosis.","volume":"8","author":"Gridelli","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R214-40-20250207","doi-asserted-by":"crossref","first-page":"243250","DOI":"10.1002\/lt.22240","article-title":"Liver transplantation in patients with cystic fibrosis: analysis of United Network for Organ Sharing data.","volume":"17","author":"Mendizabal","year":"2011","journal-title":"Liver Transpl"},{"key":"R215-40-20250207","first-page":"254624","article-title":"Liver and combined lung and liver transplantation for cystic fibrosis: analysis of the UNOS database.","volume":"15","author":"Arnon","year":"2011","journal-title":"Pediatr Transpl"},{"key":"R216-40-20250207","doi-asserted-by":"crossref","first-page":"11521156","DOI":"10.1016\/S0022-3468(03)00260-4","article-title":"Liver transplantation in children with cystic fibrosis: a longterm longitudinal review of a single centers experience.","volume":"38","author":"Fridell","year":"2003","journal-title":"J Pediatr Surg"},{"key":"R217-40-20250207","doi-asserted-by":"crossref","first-page":"246255","DOI":"10.1111\/j.1432-2277.2004.00013.x","article-title":"Effects of liver transplantation on the nutritional status of patients with cystic fibrosis.","volume":"18","author":"Colombo","year":"2005","journal-title":"Transpl Int"},{"key":"R218-40-20250207","doi-asserted-by":"crossref","first-page":"954964","DOI":"10.1111\/j.1600-6143.2011.03904.x","article-title":"Longterm impact of liver transplantation on respiratory function and nutritional status in children and adults with cystic fibrosis.","volume":"12","author":"Dowman","year":"2012","journal-title":"Am J Transpl"},{"key":"R219-40-20250207","doi-asserted-by":"crossref","first-page":"12491256","DOI":"10.1002\/lt.22139","article-title":"Pretransplant risk factors for newonset diabetes mellitus after transplant in pediatric liver transplant recipients.","volume":"16","author":"Kuo","year":"2010","journal-title":"Liver Transpl"},{"key":"R220-40-20250207","doi-asserted-by":"crossref","first-page":"19011910","DOI":"10.1111\/j.1600-6143.2008.02342.x","article-title":"Renal histopathological lesions after lung transplantation in patients with cystic fibrosis.","volume":"8","author":"Lefaucheur","year":"2008","journal-title":"Am J Transpl"},{"key":"R221-40-20250207","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1111\/j.1399-0012.2010.01395.x","article-title":"Outcomes of patients with cystic fibrosis undergoing lung transplantation with and without cystic fibrosisassociated liver cirrhosis.","volume":"26","author":"Nash","year":"2012","journal-title":"Clin Transpl"},{"key":"R222-40-20250207","doi-asserted-by":"crossref","first-page":"162169","DOI":"10.1111\/j.1600-6143.2007.02028.x","article-title":"Cystic fibrosis liver disease: to transplant or not to transplant?","volume":"8","author":"Nash","year":"2008","journal-title":"Am J Transpl"},{"key":"R223-40-20250207","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1172-7-32","article-title":"Suggested guidelines for the diagnosis and management of urea cycle disorders.","volume":"7","author":"Haberle","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"R224-40-20250207","doi-asserted-by":"crossref","first-page":"127170","DOI":"10.1016\/S0065-3101(24)00072-0","article-title":"Urea cycle disorders: diagnosis, pathophysiology, and therapy.","volume":"43","author":"Brusilow","year":"1996","journal-title":"Advances in pediatrics"},{"issue":"Suppl 1","key":"R225-40-20250207","first-page":"S8691","article-title":"Problems in the management of urea cycle disorders.","volume":"81","author":"Wilcken","year":"2004","journal-title":"Mol Genet Metab"},{"key":"R226-40-20250207","doi-asserted-by":"crossref","first-page":"e523526","DOI":"10.1542\/peds.2004-0198","article-title":"Developmental outcomes with early orthotopic liver transplantation for infants with neonatalonset urea cycle defects and a female patient with lateonset ornithine transcarbamylase deficiency.","volume":"114","author":"McBride","year":"2004","journal-title":"Pediatrics"},{"key":"R227-40-20250207","doi-asserted-by":"crossref","first-page":"440447","DOI":"10.1111\/j.1600-6143.2006.01626.x","article-title":"Livingrelated versus deceased donor pediatric liver transplantation: a multivariate analysis of technical and immunological complications in 235 recipients.","volume":"7","author":"Bourdeaux","year":"2007","journal-title":"Am J Transplant"},{"key":"R228-40-20250207","doi-asserted-by":"crossref","first-page":"13321342","DOI":"10.1002\/lt.20587","article-title":"Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University.","volume":"11","author":"Morioka","year":"2005","journal-title":"Liver Transpl"},{"issue":"Suppl 1","key":"R229-40-20250207","first-page":"S8487","article-title":"Early orthotopic liver transplantation in urea cycle defects: follow up of a developmental outcome study.","volume":"100","author":"Campeau","year":"2010","journal-title":"Mol Genet Metab"},{"issue":"Suppl 1","key":"R230-40-20250207","first-page":"S7478","article-title":"The role of liver transplantation in urea cycle disorders.","volume":"81","author":"Leonard","year":"2004","journal-title":"Mol Genet Metab"},{"key":"R231-40-20250207","doi-asserted-by":"crossref","first-page":"623628","DOI":"10.1097\/01.tp.0000167995.46778.72","article-title":"Living donor liver transplantation for noncirrhotic inheritable metabolic liver diseases: impact of the use of heterozygous donors.","volume":"80","author":"Morioka","year":"2005","journal-title":"Transplantation"},{"key":"R232-40-20250207","doi-asserted-by":"crossref","first-page":"E196200","DOI":"10.1111\/j.1399-3046.2012.01716.x","article-title":"Living donor liver transplantation from an asymptomatic mother who was a carrier for ornithine transcarbamylase deficiency.","volume":"16","author":"Wakiya","year":"2012","journal-title":"Pediatr Transpl"},{"issue":"Suppl 20","key":"R233-40-20250207","first-page":"S8994","article-title":"Diagnosis and management of CriglerNajjar syndrome.","volume":"158","author":"Jansen","year":"1999","journal-title":"Eur J Pediatr"},{"key":"R234-40-20250207","first-page":"335336","article-title":"CriglerNajjar syndrome: treatment at home with phototherapy.","volume":"33","author":"OReilly","year":"1988","journal-title":"Scott Med J"},{"key":"R235-40-20250207","doi-asserted-by":"crossref","first-page":"306319","DOI":"10.1007\/s00431-005-0055-2","article-title":"Management of hyperbilirubinemia and prevention of kernicterus in 20 patients with CriglerNajjar disease.","volume":"165","author":"Strauss","year":"2006","journal-title":"Eur J Pediatr"},{"key":"R236-40-20250207","first-page":"32363241","article-title":"Liver disorders in children: the indications for liver replacement in parenchymal and metabolic diseases.","volume":"19","author":"Mowat","year":"1987","journal-title":"Transplant Proc"},{"key":"R237-40-20250207","doi-asserted-by":"crossref","first-page":"311315","DOI":"10.1002\/hep.510240205","article-title":"Current therapy for CriglerNajjar syndrome type 1: report of a world registry.","volume":"24","author":"van der Veere","year":"1996","journal-title":"Hepatology"},{"key":"R238-40-20250207","first-page":"297306","article-title":"Autoimmune hepatitis in children: what is different from adult AIH?","volume":"29","author":"MieliVergani","year":"2009","journal-title":"Semin Liver Dis"},{"key":"R239-40-20250207","doi-asserted-by":"crossref","first-page":"544553","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitissclerosing cholangitis overlap syndrome in childhood: a 16year prospective study.","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"R240-40-20250207","first-page":"158164","article-title":"Autoimmune hepatitis.","volume":"49","author":"MieliVergani","year":"2009","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R241-40-20250207","doi-asserted-by":"crossref","first-page":"393401","DOI":"10.1002\/lt.22244","article-title":"Outcomes in children who underwent transplantation for autoimmune hepatitis.","volume":"17","author":"Martin","year":"2011","journal-title":"Liver Transpl"},{"key":"R242-40-20250207","doi-asserted-by":"crossref","first-page":"461469","DOI":"10.1002\/lt.22018","article-title":"Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry.","volume":"16","author":"Schramm","year":"2010","journal-title":"Liver Transpl"},{"key":"R243-40-20250207","first-page":"14351436","article-title":"Adult and pediatric liver transplantation for autoimmune hepatitis.","volume":"35","author":"Heffron","year":"2003","journal-title":"Transpl Proc"},{"key":"R244-40-20250207","doi-asserted-by":"crossref","first-page":"505513","DOI":"10.1053\/jlts.2002.33485","article-title":"Autoimmune hepatitis after liver transplantation and other lessons of selfintolerance.","volume":"8","author":"Czaja","year":"2002","journal-title":"Liver Transpl"},{"key":"R245-40-20250207","doi-asserted-by":"crossref","first-page":"519526","DOI":"10.1053\/jlts.2002.32981","article-title":"Incidence and recurrence of autoimmunealloimmune hepatitis in liver transplant recipients.","volume":"8","author":"Molmenti","year":"2002","journal-title":"Liver Transpl"},{"key":"R246-40-20250207","first-page":"33603367","article-title":"Autoimmune paediatric liver disease.","volume":"14","author":"MieliVergani","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R247-40-20250207","doi-asserted-by":"crossref","first-page":"126139","DOI":"10.1016\/j.jaut.2012.11.002","article-title":"Autoimmune hepatitis: a comprehensive review.","volume":"41","author":"Liberal","year":"2013","journal-title":"J Autoimmun"},{"key":"R248-40-20250207","doi-asserted-by":"crossref","first-page":"374385","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue.","volume":"54","author":"Boberg","year":"2011","journal-title":"J Hepatol"},{"key":"R249-40-20250207","doi-asserted-by":"crossref","first-page":"746764","DOI":"10.1002\/hep.21337","article-title":"Primary sclerosing cholangitis: summary of a workshop.","volume":"44","author":"LaRusso","year":"2006","journal-title":"Hepatology"},{"key":"R250-40-20250207","doi-asserted-by":"crossref","first-page":"21102113","DOI":"10.1002\/hep.26330","article-title":"Immunoglobulin G4associated cholangitis: dominating immunoglobulin G4positive clones within the Bcell receptor repertoire indicate light at the end of a long tunnel.","volume":"57","author":"Manns","year":"2013","journal-title":"Hepatology"},{"key":"R251-40-20250207","doi-asserted-by":"crossref","first-page":"463471","DOI":"10.1002\/hep.21700","article-title":"Immunoglobin G4hepatopathy: association of immunoglobin G4bearing plasma cells in liver with autoimmune pancreatitis.","volume":"46","author":"Umemura","year":"2007","journal-title":"Hepatology"},{"key":"R252-40-20250207","doi-asserted-by":"crossref","first-page":"109111","DOI":"10.1097\/MPG.0b013e31820e82a1","article-title":"A 3yearold with immunoglobulin G4associated cholangitis.","volume":"53","author":"Ibrahim","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R253-40-20250207","doi-asserted-by":"crossref","first-page":"925933","DOI":"10.1002\/lt.22320","article-title":"Pediatric liver transplantation for primary sclerosing cholangitis.","volume":"17","author":"Miloh","year":"2011","journal-title":"Liver Transpl"},{"key":"R254-40-20250207","doi-asserted-by":"crossref","first-page":"16771682","DOI":"10.1111\/j.1572-0241.2007.01220.x","article-title":"Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitis.","volume":"102","author":"Bjornsson","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R256-40-20250207","doi-asserted-by":"crossref","first-page":"660678","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis.","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"R257-40-20250207","doi-asserted-by":"crossref","first-page":"13641369","DOI":"10.1016\/j.gastro.2003.07.011","article-title":"Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community.","volume":"125","author":"Bambha","year":"2003","journal-title":"Gastroenterology"},{"key":"R258-40-20250207","doi-asserted-by":"crossref","first-page":"295302","DOI":"10.1097\/MPG.0b013e3181bf0ef7","article-title":"Childhood autoimmune liver disease: indications and outcome of liver transplantation.","volume":"50","author":"Chai","year":"2010","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R259-40-20250207","doi-asserted-by":"crossref","first-page":"728736","DOI":"10.1055\/s-0031-1273427","article-title":"Cholestatic liver diseases from child to adult: the diversity of MDR3 disease.","volume":"49","author":"Kubitz","year":"2011","journal-title":"Z Gastroenterol"},{"key":"R260-40-20250207","doi-asserted-by":"crossref","first-page":"241252","DOI":"10.1097\/MPG.0b013e3181596060","article-title":"Update on progressive familial intrahepatic cholestasis.","volume":"46","author":"Alissa","year":"2008","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R261-40-20250207","doi-asserted-by":"crossref","first-page":"119126","DOI":"10.1053\/j.gastro.2006.10.034","article-title":"Novel resequencing chip customized to diagnose mutations in patients with inherited syndromes of intrahepatic cholestasis.","volume":"132","author":"Liu","year":"2007","journal-title":"Gastroenterology"},{"key":"R262-40-20250207","doi-asserted-by":"crossref","first-page":"20492060","DOI":"10.1002\/hep.23586","article-title":"A flippaseindependent function of ATP8B1, the protein affected in familial intrahepatic cholestasis type 1, is required for apical protein expression and microvillus formation in polarized epithelial cells.","volume":"51","author":"Verhulst","year":"2010","journal-title":"Hepatology"},{"key":"R263-40-20250207","first-page":"16451655","article-title":"ATP8B1 and ABCB11 analysis in 62 children with normal gammaglutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.","volume":"51","author":"DavitSpraul","year":"2010","journal-title":"Hepatology"},{"key":"R264-40-20250207","doi-asserted-by":"crossref","first-page":"501505","DOI":"10.1016\/j.jpedsurg.2011.08.010","article-title":"Normalization of serum bile acids after partial external biliary diversion indicates an excellent longterm outcome in children with progressive familial intrahepatic cholestasis.","volume":"47","author":"Schukfeh","year":"2012","journal-title":"J Pediatr Surg"},{"key":"R265-40-20250207","doi-asserted-by":"crossref","first-page":"7383","DOI":"10.1097\/MPG.0b013e3181f50363","article-title":"Clinical features and genotypephenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations.","volume":"52","author":"Colombo","year":"2011","journal-title":"J Pediatr Gastroenter Nutr"},{"issue":"Suppl 1","key":"R266-40-20250207","first-page":"3543","article-title":"Liver disease in alpha1 antitrypsin deficiency: current understanding and future therapy.","volume":"10","author":"Hori","year":"2013","journal-title":"COPD"},{"key":"R267-40-20250207","doi-asserted-by":"crossref","first-page":"13161321","DOI":"10.1056\/NEJM197606102942404","article-title":"Liver disease in alpha1antitrypsin deficiency detected by screening of 200,000 infants.","volume":"294","author":"Sveger","year":"1976","journal-title":"N Engl J Med"},{"key":"R268-40-20250207","first-page":"514517","article-title":"The liver in adolescents with alpha 1antitrypsin deficiency.","volume":"22","author":"Sveger","year":"1995","journal-title":"Hepatology"},{"key":"R269-40-20250207","doi-asserted-by":"crossref","first-page":"864870","DOI":"10.1016\/S0022-3476(05)80123-4","article-title":"Liver disease in alpha1antitrypsin deficiency: prognostic indicators.","volume":"117","author":"Ibarguen","year":"1990","journal-title":"J Pediatr"},{"key":"R270-40-20250207","first-page":"258263","article-title":"Alpha1antitrypsin deficiencyassociated liver disease progresses slowly in some children.","volume":"31","author":"Volpert","year":"2000","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R271-40-20250207","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/hep.21009","article-title":"Hepatocellular carcinoma in a 12yearold child with PiZZ alpha1antitrypsin deficiency.","volume":"43","author":"Hadzic","year":"2006","journal-title":"Hepatology"},{"key":"R272-40-20250207","doi-asserted-by":"crossref","first-page":"229232","DOI":"10.1126\/science.1190354","article-title":"An autophagyenhancing drug promotes degradation of mutant alpha1antitrypsin Z and reduces hepatic fibrosis.","volume":"329","author":"Hidvegi","year":"2010","journal-title":"Science"},{"key":"R273-40-20250207","doi-asserted-by":"crossref","first-page":"271274","DOI":"10.1016\/j.clinre.2012.03.020","article-title":"Progressive familial intrahepatic cholestasis and inborn errors of bile acid synthesis.","volume":"36","author":"Jankowska","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R274-40-20250207","doi-asserted-by":"crossref","first-page":"315334","DOI":"10.1007\/s10024-002-1201-8","article-title":"Bile acid synthetic defects and liver disease: a comprehensive review.","volume":"7","author":"Bove","year":"2004","journal-title":"Pediatr Dev Pathol"},{"key":"R275-40-20250207","doi-asserted-by":"crossref","first-page":"593604","DOI":"10.1007\/s10545-010-9259-3","article-title":"Disorders of bile acid synthesis.","volume":"34","author":"Clayton","year":"2011","journal-title":"J Inherit Metabol Dis"},{"issue":"Suppl 1","key":"R276-40-20250207","first-page":"S1722","article-title":"Defects in bile acid biosynthesisdiagnosis and treatment.","volume":"43","author":"Setchell","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R277-40-20250207","doi-asserted-by":"crossref","first-page":"456468","DOI":"10.1038\/ncpgasthep1179","article-title":"Mechanisms of disease: Inborn errors of bile acid synthesis.","volume":"5","author":"Sundaram","year":"2008","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"R278-40-20250207","doi-asserted-by":"crossref","first-page":"10671076","DOI":"10.3748\/wjg.v18.i10.1067","article-title":"Differential diagnosis in patients with suspected bile acid synthesis defects.","volume":"18","author":"Haas","year":"2012","journal-title":"World J Gastroenterol"},{"key":"R279-40-20250207","doi-asserted-by":"crossref","first-page":"13101320","DOI":"10.1053\/j.gastro.2009.07.043","article-title":"Oral cholic acid for hereditary defects of primary bile acid synthesis: a safe and effective longterm therapy.","volume":"137","author":"Gonzales","year":"2009","journal-title":"Gastroenterology"},{"key":"R280-40-20250207","doi-asserted-by":"crossref","first-page":"258263","DOI":"10.1203\/PDR.0b013e3181eb0188","article-title":"Molecular genetic and bile acid profiles in two Japanese patients with 3betahydroxyDELTA5C27steroid dehydrogenaseisomerase deficiency.","volume":"68","author":"Mizuochi","year":"2010","journal-title":"Pediatr Res"},{"key":"R281-40-20250207","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.1097\/MPG.0b013e3181b47b34","article-title":"Variable clinical spectrum of the most common inborn error of bile acid metabolism3betahydroxyDelta 5C27steroid dehydrogenase deficiency.","volume":"50","author":"Subramaniam","year":"2010","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R282-40-20250207","doi-asserted-by":"crossref","first-page":"675678","DOI":"10.1542\/peds.103.3.675","article-title":"Tyrosinemia type 1 should be suspected in infants with severe coagulopathy even in the absence of other signs of liver failure.","volume":"103","author":"Croffie","year":"1999","journal-title":"Pediatrics"},{"key":"R283-40-20250207","first-page":"400405","article-title":"Liver transplantation for hereditary tyrosinemia type I: analysis of the UNOS database.","volume":"15","author":"Arnon","year":"2011","journal-title":"Pediatr Transpl"},{"key":"R284-40-20250207","doi-asserted-by":"crossref","first-page":"310315","DOI":"10.1016\/j.ymgme.2006.07.009","article-title":"Tyrosinemia type I treated by NTBC: how does AFP predict liver cancer?","volume":"89","author":"Koelink","year":"2006","journal-title":"Mol Genet Metab"},{"key":"R285-40-20250207","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1172-8-8","article-title":"Recommendations for the management of tyrosinaemia type 1.","volume":"8","author":"de Laet","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"R286-40-20250207","doi-asserted-by":"crossref","first-page":"115120","DOI":"10.1016\/j.spen.2006.06.007","article-title":"Glycogen storage disease: clinical, biochemical, and molecular heterogeneity.","volume":"13","author":"Shin","year":"2006","journal-title":"Semin Pediatr Neurol"},{"key":"R287-40-20250207","doi-asserted-by":"crossref","first-page":"432436","DOI":"10.1111\/j.1399-0012.2011.01549.x","article-title":"Outcomes of liver transplantation for glycogen storage disease: a matchedcontrol study and a review of literature.","volume":"26","author":"Maheshwari","year":"2012","journal-title":"Clin Transplant"},{"key":"R288-40-20250207","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1750-1172-6-27","article-title":"Glucose6phosphatase deficiency.","volume":"6","author":"Froissart","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"R289-40-20250207","doi-asserted-by":"crossref","first-page":"879884","DOI":"10.1111\/j.1432-2277.2003.tb00258.x","article-title":"Glycogenosis storage type I diseases and evolutive adenomatosis: an indication for liver transplantation.","volume":"16","author":"Lerut","year":"2003","journal-title":"Transpl Int"},{"key":"R290-40-20250207","doi-asserted-by":"crossref","first-page":"446463","DOI":"10.1097\/GIM.0b013e3181e655b6","article-title":"Glycogen storage disease type III diagnosis and management guidelines.","volume":"12","author":"Kishnani","year":"2010","journal-title":"Genet Med"},{"key":"R291-40-20250207","doi-asserted-by":"crossref","first-page":"621623","DOI":"10.1097\/MPG.0b013e31820e6a55","article-title":"Markedly elevated serum transaminases in glycogen storage disease type III.","volume":"52","author":"Karwowski","year":"2011","journal-title":"J Pediatr Gastroenter Nutr"},{"issue":"Suppl 2","key":"R292-40-20250207","first-page":"S4348","article-title":"Liver transplantation for glycogen storage disease types I, III, and IV.","volume":"158","author":"Matern","year":"1999","journal-title":"Eur J Pediatr"},{"key":"R293-40-20250207","doi-asserted-by":"crossref","first-page":"661664","DOI":"10.1097\/MPG.0b013e3181d29780","article-title":"Systemic progression of type IV glycogen storage disease after liver transplantation.","volume":"51","author":"Willot","year":"2010","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R294-40-20250207","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.5009\/gnl.2009.3.1.60","article-title":"Living donor liver transplantation in a Korean child with glycogen storage disease type IV and a GBE1 mutation.","volume":"3","author":"Ban","year":"2009","journal-title":"Gut Liver"},{"issue":"Suppl 1","key":"R295-40-20250207","first-page":"S7176","article-title":"Liver transplantation for type I and type IV glycogen storage disease.","volume":"152","author":"Selby","year":"1993","journal-title":"Eur J Pediatr"},{"key":"R296-40-20250207","doi-asserted-by":"crossref","first-page":"137145","DOI":"10.1111\/j.1399-3046.2007.00803.x","article-title":"Liver transplantation in children with glycogen storage disease: controversies and evaluation of the riskbenefit of this procedure.","volume":"12","author":"Davis","year":"2008","journal-title":"Pediatr Transpl"},{"key":"R297-40-20250207","doi-asserted-by":"crossref","first-page":"477502","DOI":"10.1146\/annurev.physiol.64.082201.154705","article-title":"Fatty acid oxidation disorders.","volume":"64","author":"Rinaldo","year":"2002","journal-title":"Annu Rev Physiol"},{"key":"R298-40-20250207","doi-asserted-by":"crossref","first-page":"18941904","DOI":"10.1002\/hep.22284","article-title":"Disturbed hepatic carbohydrate management during high metabolic demand in mediumchain acylCoA dehydrogenase (MCAD)deficient mice.","volume":"47","author":"Herrema","year":"2008","journal-title":"Hepatology"},{"key":"R299-40-20250207","doi-asserted-by":"crossref","first-page":"11751177","DOI":"10.1515\/JPEM.2009.22.12.1175","article-title":"Hypoketotic hypoglycemia with myolysis and hypoparathyroidism: an unusual association in medium chain acylCoA desydrogenase deficiency (MCADD).","volume":"22","author":"Baruteau","year":"2009","journal-title":"J Pediatr Endocrinol Metabol"},{"key":"R300-40-20250207","doi-asserted-by":"crossref","first-page":"22482253","DOI":"10.1161\/01.CIR.100.22.2248","article-title":"Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.","volume":"100","author":"Bonnet","year":"1999","journal-title":"Circulation"},{"key":"R301-40-20250207","doi-asserted-by":"crossref","first-page":"97121","DOI":"10.1097\/CND.0b013e3181903126","article-title":"Metabolic myopathies: update 2009.","volume":"10","author":"van Adel","year":"2009","journal-title":"J Clin Neuromusc Dis"},{"key":"R302-40-20250207","doi-asserted-by":"crossref","first-page":"717721","DOI":"10.1002\/hep.20631","article-title":"Abnormal concentrations of esterified carnitine in bile: a feature of pediatric acute liver failure with poor prognosis.","volume":"41","author":"Shneider","year":"2005","journal-title":"Hepatology"},{"key":"R303-40-20250207","doi-asserted-by":"crossref","first-page":"489500","DOI":"10.1055\/s-2001-19037","article-title":"Fatty acid transport and mitochondrial oxidation disorders.","volume":"21","author":"Rinaldo","year":"2001","journal-title":"Semin Liver Dis"},{"key":"R304-40-20250207","doi-asserted-by":"crossref","first-page":"17231731","DOI":"10.1056\/NEJM199906033402204","article-title":"A fetal fattyacid oxidation disorder as a cause of liver disease in pregnant women.","volume":"340","author":"Ibdah","year":"1999","journal-title":"N Engl J Med"},{"key":"R305-40-20250207","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1016\/S0022-3476(97)70312-3","article-title":"Longchain 3hydroxyacylcoenzyme A dehydrogenase deficiency with the G1528C mutation: clinical presentation of thirteen patients.","volume":"130","author":"Tyni","year":"1997","journal-title":"J Pediatr"},{"key":"R306-40-20250207","doi-asserted-by":"crossref","first-page":"8793","DOI":"10.1097\/TP.0b013e31818bc0c4","article-title":"Pediatric liver transplantation for metabolic liver disease: experience at Kings College Hospital.","volume":"87","author":"Sze","year":"2009","journal-title":"Transplantation"},{"issue":"Suppl 1","key":"R307-40-20250207","first-page":"47","article-title":"The clinical spectrum of the primary hyperoxalurias and their treatment.","volume":"11","author":"Watts","year":"1998","journal-title":"J Nephrol"},{"key":"R308-40-20250207","doi-asserted-by":"crossref","first-page":"152162","DOI":"10.1016\/j.semnephrol.2008.01.008","article-title":"The primary hyperoxalurias.","volume":"28","author":"Bobrowski","year":"2008","journal-title":"Semin Nephrol"},{"key":"R309-40-20250207","doi-asserted-by":"crossref","first-page":"17291736","DOI":"10.1093\/ndt\/gfs078","article-title":"Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment.","volume":"27","author":"Cochat","year":"2012","journal-title":"Nephrol Dial Transpl"},{"key":"R310-40-20250207","doi-asserted-by":"crossref","first-page":"10751081","DOI":"10.1007\/s00467-006-0124-4","article-title":"Primary hyperoxaluria type 1: still challenging!.","volume":"21","author":"Cochat","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"R311-40-20250207","doi-asserted-by":"crossref","first-page":"646648","DOI":"10.1002\/lt.23642","article-title":"Sequential liver and kidney transplantation from a single living donor in two young adults with primary hyperoxaluria type 1.","volume":"19","author":"Mor","year":"2013","journal-title":"Liver Transpl"},{"key":"R312-40-20250207","doi-asserted-by":"crossref","first-page":"376379","DOI":"10.1007\/s00240-005-0495-1","article-title":"The role of preemptive liver transplantation in primary hyperoxaluria type 1.","volume":"33","author":"Kemper","year":"2005","journal-title":"Urol Res"},{"key":"R314-40-20250207","first-page":"557564","article-title":"Elective liver transplantation for the treatment of classical maple syrup urine disease.","volume":"6","author":"Strauss","year":"2006","journal-title":"Am J Transpl"},{"key":"R315-40-20250207","doi-asserted-by":"crossref","first-page":"337341","DOI":"10.1111\/j.1399-3046.2009.01227.x","article-title":"Stabilization of blood methylmalonic acid level in methylmalonic acidemia after liver transplantation.","volume":"14","author":"Chen","year":"2010","journal-title":"Pediatr Transpl"},{"key":"R316-40-20250207","doi-asserted-by":"crossref","first-page":"333345","DOI":"10.1016\/j.ymgme.2009.12.007","article-title":"Classical maple syrup urine disease and brain development: principles of management and formula design.","volume":"99","author":"Strauss","year":"2010","journal-title":"Mol Genet Metab"},{"key":"R317-40-20250207","doi-asserted-by":"crossref","first-page":"116121","DOI":"10.1016\/j.jpeds.2011.06.033","article-title":"Liver transplantation for classical maple syrup urine disease: longterm followup in 37 patients and comparative United Network for Organ Sharing experience.","volume":"160","author":"Mazariegos","year":"2012","journal-title":"J Pediatr"},{"key":"R318-40-20250207","doi-asserted-by":"crossref","first-page":"876882","DOI":"10.1002\/lt.20744","article-title":"Domino liver transplantation in maple syrup urine disease.","volume":"12","author":"Khanna","year":"2006","journal-title":"Liver Transpl"},{"issue":"Suppl 1","key":"R319-40-20250207","first-page":"714","article-title":"Role of lipid apheresis in changing times.","volume":"7","author":"SchuffWerner","year":"2012","journal-title":"Clin Res Cardiol Suppl"},{"key":"R320-40-20250207","doi-asserted-by":"crossref","first-page":"E2529","DOI":"10.1111\/j.1399-3046.2010.01383.x","article-title":"Preemptive liver transplantation in a child with familial hypercholesterolemia.","volume":"15","author":"Maiorana","year":"2011","journal-title":"Pediatr Transpl"},{"key":"R321-40-20250207","doi-asserted-by":"crossref","first-page":"15551565","DOI":"10.1002\/hep.21710","article-title":"Mitochondrial hepatopathies: advances in genetics and pathogenesis.","volume":"45","author":"Lee","year":"2007","journal-title":"Hepatology"},{"key":"R322-40-20250207","doi-asserted-by":"crossref","first-page":"259273","DOI":"10.1055\/s-2007-985071","article-title":"Liver disease in mitochondrial disorders.","volume":"27","author":"Lee","year":"2007","journal-title":"Semin Liver Dis"},{"key":"R323-40-20250207","first-page":"271280","article-title":"Paediatric liver transplantation for metabolic disorders. Part 2: Metabolic disorders with liver lesions.","volume":"35","author":"Darwish","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R324-40-20250207","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ajmg.1391","article-title":"Clinical spectrum and diagnosis of mitochondrial disorders.","volume":"106","author":"Munnich","year":"2001","journal-title":"Am J Med Genet"},{"issue":"Pt 4","key":"R325-40-20250207","first-page":"723731","article-title":"Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerasegammaA.","volume":"128","author":"Ferrari","year":"2005","journal-title":"Brain"},{"key":"R326-40-20250207","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.1097\/NRL.0b013e3181c78a89","article-title":"Polymerase gamma 1 mutations: clinical correlations.","volume":"16","author":"Milone","year":"2010","journal-title":"Neurologist"},{"key":"R327-40-20250207","doi-asserted-by":"crossref","first-page":"822824","DOI":"10.1177\/088307380001501213","article-title":"3rd. Mitochondrial DNA depletion in children.","volume":"15","author":"Tsao","year":"2000","journal-title":"J Child Neurol"},{"key":"R328-40-20250207","doi-asserted-by":"crossref","first-page":"523526","DOI":"10.1007\/s004310051324","article-title":"Endstage liver disease as the only consequence of a mitochondrial respiratory chain deficiency: no contraindication for liver transplantation.","volume":"159","author":"Rake","year":"2000","journal-title":"Eur J Pediatr"},{"key":"R329-40-20250207","first-page":"478481","article-title":"Generalised mitochondrial cytopathy is an absolute contraindication to orthotopic liver transplant in childhood.","volume":"26","author":"Thomson","year":"1998","journal-title":"J Pediatr Gastroenter Nutr"},{"issue":"Pt 7","key":"R330-40-20250207","first-page":"16851692","article-title":"The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases.","volume":"129","author":"Tzoulis","year":"2006","journal-title":"Brain"},{"key":"R331-40-20250207","doi-asserted-by":"crossref","first-page":"596598","DOI":"10.1097\/00007890-200103150-00003","article-title":"Liver transplantation for mitochondrial respiratory chain disorders: to be or not to be?","volume":"71","author":"Dhawan","year":"2001","journal-title":"Transplantation"},{"key":"R332-40-20250207","doi-asserted-by":"crossref","first-page":"633637","DOI":"10.1097\/00007890-200103150-00009","article-title":"Orthotopic liver transplantation for mitochondrial respiratory chain disorders: a study of 5 children.","volume":"71","author":"Dubern","year":"2001","journal-title":"Transplantation"},{"issue":"Suppl 2","key":"R333-40-20250207","first-page":"S8184","article-title":"Liver transplantation in mitochondrial respiratory chain disorders.","volume":"158","author":"Sokal","year":"1999","journal-title":"Eur J Pediatr"},{"key":"R334-40-20250207","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1034\/j.1399-3046.2000.00090.x","article-title":"Inappropriate liver transplantation in a child with AlpersHuttenlocher syndrome misdiagnosed as valproateinduced acute liver failure.","volume":"4","author":"Delarue","year":"2000","journal-title":"Pediatr Transpl"},{"key":"R335-40-20250207","first-page":"252256","article-title":"Liver failure in mitochondrial DNA depletion syndrome: the importance of serial neuroimaging in liver transplantation evaluation.","volume":"45","author":"deBruyn JC, Chan","year":"2007","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R336-40-20250207","doi-asserted-by":"crossref","first-page":"14801485","DOI":"10.1002\/lt.21556","article-title":"Abnormal neurological features predict poor survival and should preclude liver transplantation in patients with deoxyguanosine kinase deficiency.","volume":"14","author":"Dimmock","year":"2008","journal-title":"Liver Transpl"},{"key":"R337-40-20250207","doi-asserted-by":"crossref","first-page":"262267","DOI":"10.1016\/j.ymgme.2011.03.006","article-title":"Deoxyguanosine kinase deficiency presenting as neonatal hemochromatosis.","volume":"103","author":"Hanchard","year":"2011","journal-title":"Mol Genet Metab"},{"key":"R338-40-20250207","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1097\/MPG.0b013e31824711b7","article-title":"Congenital hepatic fibrosis and autosomal recessive polycystic kidney disease.","volume":"54","author":"Srinath","year":"2012","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R339-40-20250207","first-page":"112121","article-title":"Characteristics of congenital hepatic fibrosis in a large cohort of patients with autosomal recessive polycystic kidney disease.","volume":"144","author":"GunayAygun","year":"2013","journal-title":"Gastroenterology"},{"key":"R340-40-20250207","doi-asserted-by":"crossref","first-page":"20832088","DOI":"10.1093\/ndt\/gfr588","article-title":"Kidney and liver transplantation in patients with autosomal recessive polycystic kidney disease: a multicentric study.","volume":"27","author":"Chapal","year":"2012","journal-title":"Nephrol Dial Transpl"},{"key":"R341-40-20250207","doi-asserted-by":"crossref","first-page":"195200","DOI":"10.1111\/j.1399-3046.2012.01661.x","article-title":"Pediatric liver transplantation for fibropolycystic liver disease.","volume":"16","author":"Ko","year":"2012","journal-title":"Pediatr Transpl"},{"key":"R342-40-20250207","first-page":"17771782","article-title":"Pediatric intestinal retransplantation: techniques, management, and outcomes.","volume":"86","author":"Mazariegos","year":"2008","journal-title":"Transplantation"},{"key":"R343-40-20250207","doi-asserted-by":"crossref","first-page":"10621066","DOI":"10.1002\/lt.20763","article-title":"Isolated liver transplantation in infants with endstage liver disease due to short bowel syndrome.","volume":"12","author":"Botha","year":"2006","journal-title":"Liver Transpl"},{"key":"R344-40-20250207","doi-asserted-by":"crossref","first-page":"547551","DOI":"10.1097\/MPG.0b013e31823f42e7","article-title":"Longterm outcomes of isolated liver transplantation for short bowel syndrome and intestinal failureassociated liver disease.","volume":"54","author":"Taha","year":"2012","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R345-40-20250207","doi-asserted-by":"crossref","first-page":"525532","DOI":"10.7326\/0003-4819-132-7-200004040-00003","article-title":"Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure.","volume":"132","author":"Cavicchi","year":"2000","journal-title":"Ann Intern Med"},{"key":"R346-40-20250207","doi-asserted-by":"crossref","first-page":"330333","DOI":"10.1097\/MOT.0b013e328338c2da","article-title":"Prevention of parenteral nutritionassociated liver disease: lipid minimization.","volume":"15","author":"Cober","year":"2010","journal-title":"Curr Opin Organ Transpl"},{"key":"R347-40-20250207","doi-asserted-by":"crossref","first-page":"324329","DOI":"10.1097\/MOT.0b013e32833948be","article-title":"Current concepts in the medical management of pediatric intestinal failure.","volume":"15","author":"Rudolph","year":"2010","journal-title":"Curr Opin Organ Transpl"},{"key":"R348-40-20250207","doi-asserted-by":"crossref","first-page":"334340","DOI":"10.1097\/MOT.0b013e3283394879","article-title":"Prevention of parenteral nutritionassociated liver disease: role of omega3 fish oil.","volume":"15","author":"Fallon","year":"2010","journal-title":"Curr Opin Organ Transpl"},{"key":"R349-40-20250207","doi-asserted-by":"crossref","first-page":"327331","DOI":"10.1016\/j.jpeds.2009.08.033","article-title":"Failure of resolution of portal fibrosis during omega3 fatty acid lipid emulsion therapy in two patients with irreversible intestinal failure.","volume":"156","author":"Soden","year":"2010","journal-title":"J Pediatr"},{"key":"R350-40-20250207","first-page":"30823091","article-title":"Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk.","volume":"17","author":"Pacifico","year":"2011","journal-title":"World J Gastroenterol"},{"key":"R351-40-20250207","doi-asserted-by":"crossref","first-page":"11701175","DOI":"10.1111\/j.1365-2516.2008.01844.x","article-title":"Factor VII deficiency: defining the clinical picture and optimizing therapeutic options.","volume":"14","author":"Lapecorella","year":"2008","journal-title":"Haemophilia"},{"key":"R352-40-20250207","doi-asserted-by":"crossref","first-page":"400406","DOI":"10.1055\/s-0029-1225762","article-title":"Factor VII Deficiency.","volume":"35","author":"Mariani","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"R353-40-20250207","doi-asserted-by":"crossref","first-page":"18361837","DOI":"10.1097\/00007890-200112150-00021","article-title":"Liver transplantation for factor VII deficiency.","volume":"72","author":"Levi","year":"2001","journal-title":"Transplantation"},{"key":"R355-40-20250207","doi-asserted-by":"crossref","first-page":"19091912","DOI":"10.1097\/00007890-200206270-00010","article-title":"Treatment of a patient with hemophilia A and hepatitis C virusrelated cirrhosis by livingrelated liver transplantation from an obligate carrier donor.","volume":"73","author":"Horita","year":"2002","journal-title":"Transplantation"},{"key":"R356-40-20250207","doi-asserted-by":"crossref","first-page":"10661071","DOI":"10.1136\/adc.2010.199919","article-title":"Purpura fulminans: recognition, diagnosis and management.","volume":"96","author":"Chalmers","year":"2011","journal-title":"Arch Dis Child"},{"key":"R357-40-20250207","doi-asserted-by":"crossref","first-page":"e13381342","DOI":"10.1542\/peds.2009-2913","article-title":"Longterm subcutaneous protein C replacement in neonatal severe protein C deficiency.","volume":"127","author":"de Kort","year":"2011","journal-title":"Pediatrics"},{"key":"R358-40-20250207","doi-asserted-by":"crossref","first-page":"431439","DOI":"10.1517\/14656566.2.3.431","article-title":"Clinical management of protein C deficiency.","volume":"2","author":"Pescatore","year":"2001","journal-title":"Exp Opin Pharmacother"},{"key":"R359-40-20250207","doi-asserted-by":"crossref","first-page":"406407","DOI":"10.1097\/00007890-200208150-00019","article-title":"Multivisceral transplantation for portal hypertension and diffuse mesenteric thrombosis caused by protein C deficiency.","volume":"74","author":"Florman","year":"2002","journal-title":"Transplantation"},{"key":"R360-40-20250207","first-page":"167175","article-title":"Etiology, management, and outcome of the BuddChiari syndrome.","volume":"151","author":"Darwish Murad","year":"2009","journal-title":"Ann Intern Med"},{"key":"R361-40-20250207","doi-asserted-by":"crossref","first-page":"17291764","DOI":"10.1002\/hep.22772","article-title":"Vascular disorders of the liver.","volume":"49","author":"DeLeve","year":"2009","journal-title":"Hepatology"},{"key":"R362-40-20250207","first-page":"500508","article-title":"Determinants of survival and the effect of portosystemic shunting in patients with BuddChiari syndrome.","volume":"39","author":"Darwish Murad","year":"2004","journal-title":"Hepatology"},{"key":"R363-40-20250207","first-page":"808815","article-title":"TIPS for BuddChiari syndrome: longterm results and prognostics factors in 124 patients.","volume":"135","author":"GarciaPagan","year":"2008","journal-title":"Gastroenterology"},{"key":"R364-40-20250207","doi-asserted-by":"crossref","first-page":"627630","DOI":"10.1007\/s00270-009-9647-y","article-title":"Hepatic veins and inferior vena cava thrombosis in a child treated by transjugular intrahepatic portosystemic shunt.","volume":"33","author":"Carnevale","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R365-40-20250207","doi-asserted-by":"crossref","first-page":"540543","DOI":"10.1002\/lt.21714","article-title":"Successful liver transplantation for BuddChiari syndrome in a patient with paroxysmal nocturnal hemoglobinuria treated with the anticomplement antibody eculizumab.","volume":"15","author":"Singer","year":"2009","journal-title":"Liver Transpl"},{"key":"R366-40-20250207","doi-asserted-by":"crossref","first-page":"341345","DOI":"10.1097\/TP.0b013e3182247b05","article-title":"Longterm followup of liver transplantation for BuddChiari syndrome with antithrombotic therapy based on the etiology.","volume":"92","author":"Chinnakotla","year":"2011","journal-title":"Transplantation"},{"key":"R367-40-20250207","first-page":"133135","article-title":"Liver transplantation for BuddChiari syndrome: when is it really necessary?","volume":"14","author":"Darwish Murad","year":"2008","journal-title":"Liver Transpl"},{"key":"R368-40-20250207","first-page":"510","article-title":"Results of liver transplantation in the treatment of BuddChiari syndrome.","volume":"17","author":"Mackiewicz","year":"2012","journal-title":"Ann Transpl"},{"key":"R369-40-20250207","doi-asserted-by":"crossref","first-page":"19191923","DOI":"10.1016\/j.jpedsurg.2006.06.045","article-title":"The BuddChiari syndrome in children: the spectrum of management.","volume":"41","author":"Cauchi","year":"2006","journal-title":"J Pediatr Surg"},{"key":"R370-40-20250207","doi-asserted-by":"crossref","first-page":"10711081","DOI":"10.1002\/hep.24422","article-title":"Idiopathic noncirrhotic portal hypertension.","volume":"54","author":"Schouten","year":"2011","journal-title":"Hepatology"},{"key":"R371-40-20250207","doi-asserted-by":"crossref","first-page":"219232","DOI":"10.1053\/j.sempedsurg.2012.05.005","article-title":"Surgical management of portal hypertension in children.","volume":"21","author":"de Ville de Goyet","year":"2012","journal-title":"Semin Pediatr Surg"},{"key":"R372-40-20250207","doi-asserted-by":"crossref","first-page":"556560","DOI":"10.1023\/A:1022549018807","article-title":"Hepatopulmonary syndrome in noncirrhotic portal hypertensive patients.","volume":"48","author":"Kaymakoglu","year":"2003","journal-title":"Dig Dis Sci"},{"key":"R373-40-20250207","doi-asserted-by":"crossref","first-page":"924","DOI":"10.7326\/0003-4819-132-11-200006060-00023","article-title":"Hepatopulmonary syndrome in noncirrhotic portal hypertension.","volume":"132","author":"De","year":"2000","journal-title":"Ann Intern Med"},{"key":"R374-40-20250207","doi-asserted-by":"crossref","first-page":"12381245","DOI":"10.1053\/j.gastro.2010.06.017","article-title":"Equal efficacy of endoscopic variceal ligation and propranolol in preventing variceal bleeding in patients with noncirrhotic portal hypertension.","volume":"139","author":"Sarin","year":"2010","journal-title":"Gastroenterology"},{"key":"R375-40-20250207","doi-asserted-by":"crossref","first-page":"35263528","DOI":"10.1016\/j.transproceed.2008.06.104","article-title":"Liver failure and the need for transplantation in three patients with hepatoportal sclerosis.","volume":"40","author":"Geramizadeh","year":"2008","journal-title":"Transpl Proc"},{"key":"R377-40-20250207","doi-asserted-by":"crossref","first-page":"28142816","DOI":"10.1016\/j.transproceed.2011.07.003","article-title":"Liver transplantation for hepatopulmonary syndrome due to noncirrhotic portal hypertension.","volume":"43","author":"Maganty","year":"2011","journal-title":"Transpl Proc"},{"key":"R378-40-20250207","doi-asserted-by":"crossref","first-page":"11941198","DOI":"10.1002\/lt.21493","article-title":"A new indication for liver transplantation: nodular regenerative hyperplasia in human immunodeficiency virusinfected patients.","volume":"14","author":"Tateo","year":"2008","journal-title":"Liver Transpl"},{"key":"R379-40-20250207","doi-asserted-by":"crossref","first-page":"680686","DOI":"10.1002\/lt.21113","article-title":"Pediatric hepatopulmonary syndrome is seen with polyspleniainterrupted inferior vena cava and without cirrhosis.","volume":"13","author":"Gupta","year":"2007","journal-title":"Liver Transpl"},{"key":"R380-40-20250207","doi-asserted-by":"crossref","first-page":"16301632","DOI":"10.1097\/01.tp.0000184446.52454.69","article-title":"Liver transplantation in sickle cell anemia: a case of acute sickle cell intrahepatic cholestasis and a case of sclerosing cholangitis.","volume":"80","author":"Baichi","year":"2005","journal-title":"Transplantation"},{"key":"R381-40-20250207","doi-asserted-by":"crossref","first-page":"381392","DOI":"10.1002\/lt.22257","article-title":"Transplantation for liver failure in patients with sickle cell disease: challenging but feasible.","volume":"17","author":"Hurtova","year":"2011","journal-title":"Liver Transpl"},{"key":"R382-40-20250207","first-page":"505508","article-title":"Liver transplantation in children with sicklecell disease.","volume":"13","author":"Mekeel","year":"2007","journal-title":"Liver Transpl"},{"key":"R383-40-20250207","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/gut.46.1.1","article-title":"Hepatopulmonary syndromes.","volume":"46","author":"Krowka","year":"2000","journal-title":"Gut"},{"key":"R384-40-20250207","first-page":"276282","article-title":"Longterm outcome and management of hepatopulmonary syndrome in children.","volume":"14","author":"AlHussaini","year":"2010","journal-title":"Pediatr Transpl"},{"key":"R385-40-20250207","doi-asserted-by":"crossref","first-page":"849855","DOI":"10.1111\/j.1399-0012.2010.01378.x","article-title":"Hepatopulmonary syndrome in children is conventional liver transplantation always needed?","volume":"25","author":"Willis","year":"2011","journal-title":"Clin Transplant"},{"key":"R386-40-20250207","doi-asserted-by":"crossref","first-page":"18621868","DOI":"10.1007\/s10620-011-1600-7","article-title":"Serial pulse oximetry in hepatopulmonary syndrome.","volume":"56","author":"Kochar","year":"2011","journal-title":"Dig Dis Sci"},{"key":"R387-40-20250207","doi-asserted-by":"crossref","first-page":"206214","DOI":"10.1002\/lt.20931","article-title":"Costeffectiveness of screening for hepatopulmonary syndrome in liver transplant candidates.","volume":"13","author":"Roberts","year":"2007","journal-title":"Liver Transpl"},{"key":"R388-40-20250207","doi-asserted-by":"crossref","first-page":"10421052","DOI":"10.1016\/S0016-5085(03)01207-1","article-title":"Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis.","volume":"125","author":"Schenk","year":"2003","journal-title":"Gastroenterology"},{"key":"R389-40-20250207","doi-asserted-by":"crossref","first-page":"11681175","DOI":"10.1053\/j.gastro.2008.06.038","article-title":"Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates.","volume":"135","author":"Fallon","year":"2008","journal-title":"Gastroenterology"},{"key":"R390-40-20250207","doi-asserted-by":"crossref","first-page":"11221129","DOI":"10.1002\/hep.20658","article-title":"Natural history of hepatopulmonary syndrome: impact of liver transplantation.","volume":"41","author":"Swanson","year":"2005","journal-title":"Hepatology"},{"key":"R391-40-20250207","doi-asserted-by":"crossref","first-page":"989993","DOI":"10.1097\/01.RVI.0000133225.55469.BB","article-title":"Endovascular treatment of congenital portal vein fistulas with the Amplatzer occlusion device.","volume":"15","author":"Alonso","year":"2004","journal-title":"J Vasc Interv Radiol"},{"key":"R392-40-20250207","doi-asserted-by":"crossref","first-page":"391394","DOI":"10.1002\/ppul.10182","article-title":"Abernethy malformation: one of the etiologies of hepatopulmonary syndrome.","volume":"34","author":"Alvarez","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"R393-40-20250207","doi-asserted-by":"crossref","first-page":"e2731","DOI":"10.1016\/j.jpedsurg.2011.10.079","article-title":"Congenital intrahepatic portohepatic shunt managed by interventional radiologic occlusion: a case report and literature review.","volume":"47","author":"Grimaldi","year":"2012","journal-title":"J Pediatr Surg"},{"key":"R394-40-20250207","doi-asserted-by":"crossref","first-page":"e3538","DOI":"10.1016\/j.jpedsurg.2007.11.001","article-title":"Resolution of hepatopulmonary syndrome after ligation of a portosystemic shunt in a pediatric patient with an Abernethy malformation.","volume":"43","author":"Morikawa","year":"2008","journal-title":"J Pediatr Surg"},{"key":"R395-40-20250207","doi-asserted-by":"crossref","first-page":"18131820","DOI":"10.1016\/j.jpedsurg.2008.04.002","article-title":"Liver transplantation for pulmonary vascular complications of pediatric endstage liver disease.","volume":"43","author":"Iqbal","year":"2008","journal-title":"J Pediatr Surg"},{"key":"R396-40-20250207","doi-asserted-by":"crossref","first-page":"607612","DOI":"10.1097\/MPG.0b013e3181a5267d","article-title":"Pulmonary vascular complications in asymptomatic children with portal hypertension.","volume":"49","author":"Whitworth","year":"2009","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R397-40-20250207","first-page":"861880","article-title":"Pulmonaryhepatic vascular disorders (PHD).","volume":"24","author":"RodriguezRoisin","year":"2004","journal-title":"Eur Respir J"},{"key":"R398-40-20250207","doi-asserted-by":"crossref","first-page":"466468","DOI":"10.1097\/01.mpg.0000178441.10417.0f","article-title":"Successful liver transplantation in a child with severe portopulmonary hypertension treated with epoprostenol.","volume":"41","author":"Laving","year":"2005","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R399-40-20250207","doi-asserted-by":"crossref","first-page":"881891","DOI":"10.1002\/lt.23485","article-title":"Portopulmonary hypertension: an update.","volume":"18","author":"Safdar","year":"2012","journal-title":"Liver Transpl"},{"key":"R400-40-20250207","doi-asserted-by":"crossref","first-page":"435448","DOI":"10.1016\/j.cld.2012.03.014","article-title":"Is the patient a candidate for liver transplantation?","volume":"16","author":"Fox","year":"2012","journal-title":"Clin Liver Dis"},{"key":"R401-40-20250207","doi-asserted-by":"crossref","first-page":"227247","DOI":"10.1016\/j.cld.2007.04.008","article-title":"Current indications and contraindications for liver transplantation.","volume":"11","author":"Ahmed","year":"2007","journal-title":"Clin Liver Dis"},{"key":"R402-40-20250207","doi-asserted-by":"crossref","first-page":"20102017","DOI":"10.1053\/j.gastro.2009.08.070","article-title":"Longterm probability of and mortality from de novo malignancy after liver transplantation.","volume":"137","author":"Watt","year":"2009","journal-title":"Gastroenterology"},{"key":"R403-40-20250207","doi-asserted-by":"crossref","first-page":"217221","DOI":"10.3747\/co.19.950","article-title":"Liver transplantation for symptomatic liver metastases of neuroendocrine tumours.","volume":"19","author":"Chan","year":"2012","journal-title":"Curr Oncol"},{"key":"R404-40-20250207","doi-asserted-by":"crossref","first-page":"323335","DOI":"10.1016\/j.cld.2007.04.001","article-title":"Issues unique to pediatric liver transplantation.","volume":"11","author":"Kerkar","year":"2007","journal-title":"Clin Liver Dis"},{"key":"R405-40-20250207","doi-asserted-by":"crossref","first-page":"608611","DOI":"10.1016\/j.jpeds.2011.03.017","article-title":"Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity.","volume":"159","author":"McGoogan","year":"2011","journal-title":"J Pediatr"},{"key":"R406-40-20250207","doi-asserted-by":"crossref","first-page":"282286","DOI":"10.1097\/01.mpg.0000214156.58659.4c","article-title":"Neonatal herpes simplex virus infection presenting as acute liver failure: prevalent role of herpes simplex virus type I.","volume":"42","author":"Verma","year":"2006","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R407-40-20250207","doi-asserted-by":"crossref","first-page":"330344","DOI":"10.1016\/j.ymgme.2012.03.012","article-title":"Recommendations for the diagnosis and management of NiemannPick disease type C: an update.","volume":"106","author":"Patterson","year":"2012","journal-title":"Mol Genet Metab"},{"key":"R408-40-20250207","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-5-16","article-title":"NiemannPick disease type C.","volume":"5","author":"Vanier","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"R409-40-20250207","doi-asserted-by":"crossref","first-page":"331348","DOI":"10.1111\/j.1399-0004.1988.tb03460.x","article-title":"NiemannPick disease group C: clinical variability and diagnosis based on defective cholesterol esterification. A collaborative study on 70 patients.","volume":"33","author":"Vanier","year":"1988","journal-title":"Clin Genet"},{"key":"R410-40-20250207","first-page":"4450","article-title":"Niemannpick disease type C in neonatal cholestasis at a North American Center.","volume":"35","author":"Yerushalmi","year":"2002","journal-title":"J Pediatr Gastroenter Nutr"},{"key":"R411-40-20250207","doi-asserted-by":"crossref","first-page":"242247","DOI":"10.1016\/S0022-3476(05)81695-6","article-title":"NiemannPick disease type C: diagnosis and outcome in children, with particular reference to liver disease.","volume":"123","author":"Kelly","year":"1993","journal-title":"J Pediatr"},{"key":"R412-40-20250207","doi-asserted-by":"crossref","first-page":"104106","DOI":"10.1542\/peds.77.1.104","article-title":"Progression of neurovisceral storage disease with supranuclear ophthalmoplegia following orthotopic liver transplantation.","volume":"77","author":"Gartner","year":"1986","journal-title":"Pediatrics"},{"key":"R413-40-20250207","doi-asserted-by":"crossref","first-page":"305309","DOI":"10.1002\/mpo.1340","article-title":"Biology and treatment of familial hemophagocytic lymphohistiocytosis: importance of perforin in lymphocytemediated cytotoxicity and triggering of apoptosis.","volume":"38","author":"Henter","year":"2002","journal-title":"Med Pediatr Oncol"},{"key":"R414-40-20250207","doi-asserted-by":"crossref","first-page":"417433","DOI":"10.1016\/S0889-8588(05)70520-7","article-title":"Familial hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis.","volume":"12","author":"Henter","year":"1998","journal-title":"Hematol Oncol Clin N Am"},{"key":"R415-40-20250207","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jpeds.2007.04.037","article-title":"Fetal hemophagocytic lymphohistiocytosis in a premature infant.","volume":"151","author":"Nitta","year":"2007","journal-title":"J Pediatr"},{"key":"R416-40-20250207","doi-asserted-by":"crossref","first-page":"360366","DOI":"10.1007\/s100249900135","article-title":"Hemophagocytic syndrome presenting as acute hepatic failure in two infants: clinical overlap with neonatal hemochromatosis.","volume":"2","author":"Parizhskaya","year":"1999","journal-title":"Pediatr Dev Pathol"},{"key":"R417-40-20250207","doi-asserted-by":"crossref","first-page":"573581","DOI":"10.1007\/s00431-010-1309-1","article-title":"Neonatal liver failure: aetiologies and managementstate of the art.","volume":"170","author":"Shanmugam","year":"2011","journal-title":"Eur J Pediatr"},{"key":"R418-40-20250207","doi-asserted-by":"crossref","first-page":"864871","DOI":"10.1053\/he.2000.5852","article-title":"A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.","volume":"31","author":"Malinchoc","year":"2000","journal-title":"Hepatology"},{"key":"R419-40-20250207","doi-asserted-by":"crossref","first-page":"173181","DOI":"10.1097\/00007890-200207270-00006","article-title":"Development of a pediatric endstage liver disease score to predict poor outcome in children awaiting liver transplantation.","volume":"74","author":"McDiarmid","year":"2002","journal-title":"Transplantation"},{"key":"R420-40-20250207","doi-asserted-by":"crossref","first-page":"737738","DOI":"10.1002\/lt.20451","article-title":"A critical analysis to a critical analysis: breaking the circle of organ allocation in the United States.","volume":"11","author":"Reyes","year":"2005","journal-title":"Liver Transpl"},{"key":"R421-40-20250207","doi-asserted-by":"crossref","first-page":"788795","DOI":"10.1002\/lt.20401","article-title":"Critical analysis of the pediatric endstage liver disease scoring system: a single center experience.","volume":"11","author":"Shneider","year":"2005","journal-title":"Liver Transpl"},{"key":"R422-40-20250207","doi-asserted-by":"crossref","first-page":"18681874","DOI":"10.1111\/j.1600-6143.2005.00962.x","article-title":"Regional variation and use of exception letters for cadaveric liver allocation in children with chronic liver disease.","volume":"5","author":"Salvalaggio","year":"2005","journal-title":"Am J Transpl"},{"key":"R423-40-20250207","first-page":"22442247","article-title":"Regional variations in peer reviewed liver allocation under the MELD system.","volume":"5","author":"RodriguezLuna","year":"2005","journal-title":"Am J Transpl"},{"key":"R425-40-20250207","first-page":"3134","article-title":"Evolution in allocation rules for renal, hepatic, pancreatic and intestinal grafts.","volume":"108","author":"Desschans","year":"2008","journal-title":"Acta Chir Belg"},{"key":"R426-40-20250207","doi-asserted-by":"crossref","first-page":"426430","DOI":"10.1002\/lt.22000","article-title":"Modified pediatric endstage liver disease scoring system and pediatric liver transplantation in Brazil.","volume":"16","author":"Neto","year":"2010","journal-title":"Liver Transpl"},{"key":"R427-40-20250207","first-page":"196201","article-title":"Status and Current Problems in the Allocation System for Pediatric Liver Transplantation in Korea.","volume":"26","author":"Choi","year":"2012","journal-title":"J Korean Soc Transplant"},{"key":"R429-40-20250207","doi-asserted-by":"crossref","first-page":"489491","DOI":"10.1097\/TP.0b013e318205b3ab","article-title":"New organ transplant policies in Japan, including the familyoriented priority donation clause.","volume":"91","author":"Aita","year":"2011","journal-title":"Transplantation"},{"key":"R431-40-20250207","doi-asserted-by":"crossref","first-page":"145154","DOI":"10.1097\/SLA.0b013e31821ad86a","article-title":"A multivariate analysis of pre, peri, and posttransplant factors affecting outcome after pediatric liver transplantation.","volume":"254","author":"McDiarmid","year":"2011","journal-title":"Ann Surg"},{"key":"R432-40-20250207","doi-asserted-by":"crossref","first-page":"301310","DOI":"10.1097\/SLA.0b013e3180caa415","article-title":"Impact of graft type on outcome in pediatric liver transplantation: a report from Studies of Pediatric Liver Transplantation (SPLIT).","volume":"246","author":"Diamond","year":"2007","journal-title":"Ann Surg"},{"key":"R433-40-20250207","doi-asserted-by":"crossref","first-page":"540545","DOI":"10.1097\/00007890-199908270-00017","article-title":"Analysis of survival and morbidity after pediatric liver transplantation with fullsize and technicalvariant grafts.","volume":"68","author":"Sieders","year":"1999","journal-title":"Transplantation"},{"key":"R434-40-20250207","doi-asserted-by":"crossref","first-page":"467468","DOI":"10.1016\/S0041-1345(96)00206-0","article-title":"Sequential liver transplantation.","volume":"29","author":"Furtado","year":"1997","journal-title":"Transpl Proc"},{"key":"R435-40-20250207","doi-asserted-by":"crossref","first-page":"116121","DOI":"10.1016\/j.jpeds.2011.06.033","article-title":"Liver transplantation for classical maple syrup urine disease: longterm followup in 37 patients and comparative United Network for Organ Sharing experience.","volume":"160","author":"Mazariegos","year":"2012","journal-title":"J Pediatr"},{"key":"R436-40-20250207","doi-asserted-by":"crossref","first-page":"782785","DOI":"10.1097\/TP.0b013e3181eefe1f","article-title":"Early renal failure after domino liver transplantation using organs from donors with primary hyperoxaluria type 1.","volume":"90","author":"Saner","year":"2010","journal-title":"Transplantation"},{"key":"R437-40-20250207","first-page":"249254","article-title":"Domino as a bridge to definitive liver transplantation in a neonate.","volume":"6","author":"CasasMelley","year":"2002","journal-title":"Pediatr Transpl"},{"key":"R438-40-20250207","doi-asserted-by":"crossref","first-page":"14811486","DOI":"10.1097\/01.TP.0000113809.53415.C2","article-title":"Hepatocyte transplantation.","volume":"77","author":"Horslen","year":"2004","journal-title":"Transplantation"},{"key":"R439-40-20250207","doi-asserted-by":"crossref","first-page":"864875","DOI":"10.3748\/wjg.14.864","article-title":"Stem cells for liver tissue repair: current knowledge and perspectives.","volume":"14","author":"Lysy","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R440-40-20250207","doi-asserted-by":"crossref","first-page":"769774","DOI":"10.1016\/j.jhep.2010.05.010","article-title":"Barriers to the successful treatment of liver disease by hepatocyte transplantation.","volume":"53","author":"Soltys","year":"2010","journal-title":"J Hepatol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.27191","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201407000-00040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T12:07:04Z","timestamp":1738930024000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201407000-00040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":423,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.27191","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}